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Abbreviations  
 
APS  ammoniumpersulfat 
BSA  bovine serum albumin 
BS12  bottom strand 12 nucleotides 
CP  cell pellet 
COB1 cytochrome b gene-1 
COX1 cyclooxygenase-1 
CspA cold-shock protein A 
DbpA DEAD-box protein A  
DEAD  amino acid code for D – aspartic acid, E – glutamic acid, A – alanine 
DMS dimethylsulfid 
dsRNA double-stranded ribonucleic acid 
DTT  dithiothreitol 
EBS  exon binding site 
EDTA  ethylenediaminetetraacetic acid 
GTS  glycerol tris sodiumchloride buffer 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HIS  histidine tag 
IBS  intron binding site 
IGEPAL synonym for octylphenyl-polyethylene glycol 
IPTG  isopropyl-β-D-thiogalactopyranosid 
KAN  kanamycin 
LB  lysogeny broth medium 
ME  MOPS EDTA buffer 
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MOPS  3-(N-morpholino)propanesulfonic acid 
mRNA messenger ribonucleic acid 
Mss116p  mitochondrial splicing system Saccharomyces cerevisiae, protein number 116   
NAIM nucleotide analog interference mapping 
NAIS nucleotide analog interference suppression 
Ni-NTA  nickel nitrolotriacetic acid 
OD600  optical density at 600 nm 
ORF open reading frame 
o/n  overnight 
PAGE  polyacrylamide gel electrophoresis 
PCI  phenol chloroform isoamylalcohol 
PNK  polynucleotide kinase 
RNA ribonucleic acid 
RNP ribonucleoprotein 
rpm rounds per minute 
RT reverse transcription 
Sc160  saccharomyces cerevisiae primer 
SDS  sodium dodecyl sulfate 
SF1/2 super family 1/2 helicase 
SN  supernatant 
snRNA small nuclear ribonucleic acid 
SOC  super optimal broth medium 
ssRNA single stranded ribonucleic acid 
StpA DNA-binding protein stpA in E. coli 
SUMO  small ubiquitin-like modifiers 
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TBE  tris borate EDTA buffer 
TEMED  tetramethylethylendiamin 
TEV tobacco etch virus 
TRA  transcription buffer 
TRIS  trisamine 
TS12  top strand 12 nucleotides 
w/t wild type 
  
10 
Introduction 
 
An RNA World  
 
RNA is a powerful and highly fascinating molecule which played a striking role during evolution 
throughout billions of years. Therefore the idea of a primordial RNA molecule has already been 
hypothesized in the 1960ies by Crick (1968), Orgel (1968) and Woese (1967), and resulted in an 
‘RNA world’ concept two decades 
thereafter (Gilbert 1986) – with the 
discovery of catalytic RNA by Cech 
and Altman (7, 8). This concept 
(Figure 1), where RNA appeared 
first in time during evolution of life 
on earth, is supported by a number 
of arguments and is currently 
widely accepted. The basis of this 
model states a set of complex organic molecules which were produced by random chemistry. The 
majority of the molecules died out but one pathway proceeded and led to self-replicating RNA. 
The additional arrow around the term “RNA world” indicates potential self-replicating systems 
which further supported the development of self-replicating RNA. Proteins came about after RNA 
was present, although amino acis and peptides were present in an RNA world, to catalyze 
peptide bond formation and amino acid polymerization. DNA is believed to have evolved more 
recently and this aspect is supported by the fact that LUCA (Last Universal Common Ancestor) 
already had a DNA genome using biochemical catalysis, enzymes and RNP complexes (2).  
Figure 1: The ’RNA world’ model. First complex organic molecules which 
proceeded a primordial RNA world evolved. Supported by organic 
molecules self-replicating RNA systems developed. Due to the presence 
of amino acids and peptides it is hypothesized that proteins followed in 
time during evolution. LUCA (Last Universal Common Ancestor) is 
believed to evolve recently < 1 billion years, which already carried a DNA 
genome (2).  
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Many arguments support an RNA world model and one of them is that RNA can be both - 
genotype and phenotype, and that RNA is able to perform self-replication chemistry (9). 
Therefore the likelihood seems greater that one molecule, RNA, appeared first which is able to 
perform both functions than two separate molecules, RNA and DNA, were synthesized at the 
same time and place (2). The most direct evidence for RNAs pioneering role would be a 
crystallographic approach which shows that a ribosome´s core activity (peptide bond formation) is 
driven by an RNA molecule (10). In this regard, it has to be noted that the crystal structures of the 
ribosome revealed that the peptidyl transferase center is devoid of proteins (11). Aside from the 
naturally occurring large and small ribozymes, which catalyze transesterification reactions, 
dozens of other RNA catalyzing activities were discovered by SELEX (Systematic Evolution of 
Ligands by Exponential Enrichment), which could have been crucial for RNA in a primordial RNA 
world (2) – e.g. catalyzing peptide bond formation or short RNA molecules that can duplicate 
others (12, 13) . Finally, the abundant enzymes dedicated to RNA biosynthesis and the continuity 
of the system comprises its first appearance compared to only two additional enzymes 
(thymidylate synthase and ribonucleotide reductase) which evolved for DNA (2). The above 
mentioned arguments support an RNA world concept, however, an “RNA-first” view also triggers 
a lot of unsolved problems and opinions vary as to whether an RNA self-replicating system 
appeared autonomous or is a derivative of an earlier system (2). The complexity of modern RNA 
systems raised circumspect voices which doubt its arising de novo (14, 15). Today a lot of 
different approaches, like prebiotic chemistry, synthetic biology or paleogenetics, try to offer 
experimentally accessible data and a model to explain how life might have emerged e.g. in vitro 
evolution studies (experiments on simple liposomes which grow and divide into ‘protocells’ upon 
agitation) (15-17).  
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As RNA is not only a medium to store information but also capable of performing an orchestra of 
different catalytic functions, it seems obvious why it is worth the effort and energy trying to 
decipher the basic biochemistry and structural principles of this strikingly diverse molecule.  
 
1. Basic RNA Biochemistry 
The structure of an RNA macromolecule is, as in proteins, characterized by its three organization 
levels. The first level presents the sequence, where nucleotides are connected via their sugar-
phosphate backbone. Under ionic conditions RNA folds back on itself via Watson-Crick base 
pairing between the bases constituting RNA secondary structure. The second organization level 
compasses double stranded helices interrupted by single stranded regions in internal loops or 
hairpin loops. Highly dependent on ionic and temperature conditions an RNA molecule is able to 
perform the transition into a 3-dimensional fold. Within this 3D RNA macromolecule the helices 
and single stranded regions are very well organized and are instrumental in specific biological 
functions (11). In the following chapters we take a closer look into RNA organization levels. 
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2. RNA Primary Structure 
The basis of RNAs’ first organization level, the primary structure, is alternating occurrence of 
nucleobases adenine (A), 
cytosine (C), guanine (G) and 
uracil (U). Each so called 
nucleotide element (5’-NMP) 
consists of a negatively 
charged phosphate group, a D-
ribose sugar ring and an 
aromatic nucleobase, 
pyrimidine or purine, 
respectively (Figure 2). Several 
nucleotide units are connected by its phosphates over 3’, 5’- phosphodiester bonds resulting in a 
nucleotide chain which shows 5’- to 3’- chain polarity. The chain therefore offers an array of 
biochemical features like a negatively charged sugar-phosphate backbone and a set of 
hydrophobic nucleobases with amphilic features which naturally drive the occurrence of 
secondary and tertiary RNA structures (18). 
 
  
Figure 2: DNA and RNA Watson-Crick base pairing of DNA and RNA 
duplexes (1).  
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3. RNA Secondary Structure 
In principle RNA bases offer three edges for H-bonding. They are depicted in the left panel of 
Figure 3 and comprise Watson-Crick edge, Hoogsteen edge (for purine and CH edge for 
pyrimidine) and sugar edge (includes 
2’OH group). The bases interact over 
its edges by stacking, which account 
for 90% of interactions within an RNA 
macromolecule and represents the 
major force driving RNA folding (4, 
18). Another way of base interaction is 
to join edge-to-edge, which is 
triggered by hydrogen bonds and 
gives the macromolecule 
directionality and specificity (4, 18). 
In the right panel of Figure 3 glycosidic bond orientations, that can appear as cis or trans 
orientation, are illustrated. As a matter of fact, 12 distinct edge-to-edge orientations (Table 1) are 
possible and over indicating interaction edge and orientation of the glycosidic bond of each base, 
pairing geometry can be categorized. A canonical Watson-Crick base pair (A-U or G=C) for 
example would belong to family No. 1. The so called ‘wobble’ pairs, which terms base pairing 
between non-complementary bases (G and U) (3) is characterized by a geometrical shift of one 
base relative to the other. Attention should be paid to the geometry of wobble base pairs as they 
are not strictly isosteric (in contrast to Watson-Crick base pairs), meaning that a GU wobble is not 
geometrically identical to a UG wobble (11). The overall stability of canonical base pairing 
increases as follows: G-C>A-U>G-U (wiki.case.edu). 
Figure 3: The three edges for base pair interaction. Left panel: edges for 
adenosine and cytosine. The Watson-Crick edge, the Hoogsteen edge, 
the sugar edge and the ribose hydroxyl group O2'. Right panel: showing 
a cis and trans orientation which is defined by a parallel line drawn 
between the bases hydrogen bonds (4).  
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The sum of Watson-Crick base pairs and intervening unpaired regions can appear as distinct 
structural elements which is given attention in the following chapter. This nomenclature provides 
a useful tool to present RNA structure as a two-dimensional system (19).  
 
 
 
 
 
 
 
 
 
 
 
 
Secondary Structure Elements 
A set of secondary structure elements is presented in Figure 4. The aminoacyl-tRNA offers a 
descriptive model for secondary structure element interpretation, as it is one of the best 
understood and most studied molecules due to its central role in gene expression and a high 
appearance in the cell. In a 2D and 3D model of yeast tRNAAla is given as an example. In panel 
(A) a secondary structure model demonstrates the typical clover leaf shape, consisting of three 
hairpin structures (D-, T-, anti-codon arm) and 
the acceptor stem, a large multi loop (= four way 
junction) in the center and a set of additional 
secondary structure elements (19). 
 
 
  
Table 1: displays the 12 distinct families of edge-to-edge 
orientations between two base pairs. This table assumes 
that all bases are default anti conformation with respect to 
the sugars, as syn conformation is rather rare (4). 
Figure 4: Secondary structural elements. They are defined 
by a pattern of paired and unpaired bases and represented 
by bulges, internal loops, and hairpin structures.  
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2ndry Structure Prediction 
A way to determine such a secondary level model is structure prediction with the help of 
programs (e.g. RNAfold or Mfold). Most of the programs use algorithms that predict the lowest 
free energy potential for all possible base-pairing combinations and structural elements. Reliable 
programs take into account of comparative sequence analysis (covariance of nucleotides e.g. 
exchange of one Watson-Crick pair for another: CG to an AU pair) and experimental data, like 
chemical probing and/or mutational analysis, among others. Nevertheless, such a secondary 
structure has to be verified over structural probing techniques that exploit chemicals or enzymes 
which specifically target RNA structure (e.g. DMS probing). Chemical modification sites are, like 
in our experiments, revealed by reverse transcription with a radioactive labeled DNA primer (32P 
end-labeled). Structure prediction data combined with biochemical techniques then yields to 
important information about the tertiary structure of an RNA macromolecule (19).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5: A secondary and tertiary structure representation of aminoacyl-tRNA. (a) Clover leaf 
representation of yeast alanine tRNA. Watson-Crick base pairs are indicated as blue dots. The 
World of the Cell by Becker et al, published by Pearson Education 
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4. RNA Tertiary Structure 
RNA reveals many additional edge-to-edge interactions 
which give rise to diversified tertiary motifs. The 
enumeration of these paired regions or helices, displays a 
description of a secondary structure level. As a 
consequence of growing literature on RNA biology and the 
rapid progress of RNA crystallography during the 1990ies, 
Leontis and Westhof (2001) established a geometric 
nomenclature and classification of RNA base pairing which 
unfolded a variety of base-pairing geometries. The 
nomenclature offers a way to communicate RNA structural 
information in a two-dimensional representation of complex 
3D RNA structures. 3D motifs can be specified by 
indicating interaction edges and orientation of glycosidic 
bonds of two bases.  
The tertiary organization level resulting from secondary interactions appears in a strikingly diverse 
manner and depends highly on divalent ions, temperature and cofactors. Panel (A) and (B) of 
Figure 5 show that the previously predicted secondary clover leaf structure leads to a complete 
different appearance in the 3D model. The RNA folds by co-axial stacking (tertiary motifs) of the 
D-stem onto the anticodon stem and the T-stem onto the acceptor stem, resulting in two helical 
segments. The D- and T-loops which contained unpaired bases only in the 2D structure, form 
several non-canonical base pairs enable the proper orientation of the two helical stacks to each 
other. Concerning the overall stability of a 3D RNA molecule RNA helices are not much affected 
by environmental changes. In contrast, the lack of divalent cations causes a significant change in 
tertiary interactions and structure; in particular non-canonical base pairs appear very sensitive 
Figure 6: the three forms of helical DNA 
A, B and Z. The characteristic A-form 
(middle panel) is characterized by the 
presence of a 3’-endo sugar pucker, a 
compact shape (P-P distance 5.9 Å), 
right-handed orientation and tilted bases 
to helical axis. 
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(‘wobble’ base pairs; structurally described in previous chapter). As a matter of fact they often 
play an important function serving as recognition elements for proteins, nucleic acids or ion-
binding sites (18). As demonstrated in the tRNA example above RNA adopts quite often helical 
structures. While DNA duplexes prefer the classical B-form helix, RNA adopts the very 
characteristic A-form in the third organization level which results of canonical Watson-Crick base 
pairing showing a remarkable isostericity with a strict tertiary helical structure. The structure is 
characterized by a narrow, deep major groove and a wide, exposed minor groove (Figure 6). The 
major groove has a strong negative charge and high potential for binding metal ions or protein 
side-chains. Therefore the major groove often needs help in widening the narrow groove to allow 
protein ligand interaction.  Compared to the B-form, A-form nucleobases are tilted to the helical 
axis and stacking is enforced by their ∏- electrons and plane aromatic rings, below and above 
respectively, resulting in a more compact shape. This is achieved by the C3’-endo sugar pucker, 
predominant for A-form of RNA, which allows a closer phosphate-phosphate distance (5.9 Å) than 
induced by the C2’-endo sugar pucker in B-form helices  (20).  
Other examples for tertiary structure motifs for example is the ‘ribose zipper’ which has been 
found in the P4-P6 structure within the Tetrahymena self-splicing intron (21). This tertiary motif is 
characterized by consecutive hydrogen-bonding between 2’-OH groups of the ribose from 
different regions of an RNA chain or between two RNA chains (22). The ‘tetraloop-helix 
interaction’ has also been found in the P4-P6 domain of Tetrahymena group I intron and in the 
crystal structure of the hammerhead ribozyme (21, 23). In the hammerhead structure of 
ribozymes a GAAA tetraloop interacts with a helical stem capped with a GNRA tetraloop that 
ends with Watson Crick base pairs (G-C). The Gs belonging to these Watson Crick pairs the final 
A of the capping loop; interact with all three A’s of the GAAA tetraloop. Tetraloop-helix 
interactions stabilize over hydrogen bonding interactions between NRA bases of GNRA 
tetraloops and groups found in the minor groove of helical stems (24). 
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The third organization level is the decisive factor for biological function of an RNA molecule and 
several molecular biological techniques have to be combined to get an overall image. Tertiary 
structures are identified by comparative sequence analysis close together with structural probing, 
chemogenetics, mutational analysis, homology modeling and, importantly, biophysical 
techniques, crystallography and NMR spectroscopy. But this is a very tricky challenge for RNA 
molecules as a lot of them are quite huge, highly charged and need high ion concentration to 
maintain their native, functional structure (without inducing spontaneous metal-induced cleavage) 
(25). A combination of all available approaches is therefore suggested to unveil RNA architecture, 
folding and function.  
RNA Folding and the Problem 
 
 The biological activity of an RNA molecule is highly dependent on its proper folding. Over the 
past decades the Tetrahymena group I ribozyme was thermodynamically examined and presents 
one of the best understood models for RNA 
folding. All studies and facts could be unified 
and the output was presented exactly 10 
years ago (26). A folding pathway to the 
native structure is interspersed by folding 
intermediates and most of them are on-path 
with an increased amount of native contacts. 
However, an RNA molecule can be trapped 
in non-native conformations and escaping 
such kinetic traps is often rate-limiting during 
a folding pathway (5). A multidimensional 
Figure 7: Folding landscape of wt Tetrahymena group I 
ribozyme. Likely folding pathways are indicated as folding 
channels (A,B,C). The landscape is contoured by internal free 
energy. Folding properties depend highly on initial conditions 
and ‘walls’ need to be overcome to interconverse different 
folding pathways (Russel 2001). (N) native ribozyme 
conformation; (M) misfolded structure; (Itrap) intermediate 
trap; (Ic, Ic’’ initial folding conditions at different ionic 
concentrations) (3). 
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energetic landscape is able to summarize and describe intermediate states and parallel folding 
pathways. The overall shape of a landscape provides information about thermodynamics and 
kinetics of the RNA molecule (3). Figure 7 presents a schematic of the Tetrahymena group I 
ribozyme energetic folding landscape contoured by its internal free energy. Every point in the 
landscape states information about the free energy, degrees of freedom and surrounding 
conditions of the ribozyme in a specific structural conformation. Someone can see folding funnels 
with kinetic traps (Itrap or M) along a folding pathway energetically downhill to the final folding state 
of the molecule (N). The final state can be described as the conformation with least free energy 
and is a very narrow region within the energy landscape. In general folding landscapes for RNAs 
are substantially more rugged than protein landscapes but for both a pathway is mainly 
dependent on the initial conditions (3).   
As previously mentioned the native state is a very narrow region in an energetic folding 
landscape. Therefore it is quite likely that a lot of molecules adopt non-native conformations that 
are energetically favored. Trapped folding intermediates (Itrap) and misfolded structures (M) are 
very common in folding pathways; the escape from such kinetic traps requires structural 
reorganization and is often the rate-limiting event in folding. In other words, RNA faces a 
substantial problem which is termed as ‘RNA folding problem’. Assistance to overcome the 
folding problem is provided by nature: i.) proteins and ii.) metal ions (27).  
 
1. Proteins Involved in RNA Folding 
In a living cell metal ion concentration is well below that of in vitro folding studies but two types of 
proteins showed profound features for guiding RNA to its catalytically active structure. One type 
acts as non-specific RNA chaperones without recognizing a specific sequence or structural 
element within their target RNA(s) (27). The other type though binds very tight to RNA specifically  
recognizing either RNA sequence or structural elements, thereby stabilizing RNA structure (28).  
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The E. coli proteins StpA or S12 had been shown to act as RNA chaperones, both in vitro and in 
vivo (29-31). Structural analysis using DMS modification showed that StpA offers its support by 
resolving tertiary interactions within its target RNA, the td group I intron in vivo, thereby 
destabilizing the intron structure (32). There are several other proteins which showed RNA 
chaperone activity in vitro like the cold-shock protein CspA , the yeast La protein or the tumor 
suppressor protein p53 (33, 34). Proteins like Cyt18, Cbp2 and LtrA for example were observed 
to bind specifically to their target RNAs, thereby decreasing the Mg2+ concentration required for 
proper folding in vitro (28, 35-37). For some proteins like the DEAD-box Mss116p the specific role 
remains unclear. The yeast mitochondrial splicing system (MSS) component has been shown to 
be essential for efficient splicing of all yeast group I and group II introns (6, 38). In vitro folding 
studies revealed that Mss116p stabilizes, acting as a cofactor and reducing Mg2+ concentration 
for intron folding, as well displaying unwinding and annealing activity in vitro (6, 38, 39). Unclear 
remains whether unwinding activity is essential for stimulating intron splicing and two distinct 
models for Mss116p have evolved – Mss116p functions as splicing cofactor either by acting in a 
chaperone-like manner or by providing stability to RNA structure through specific binding of intron 
regions (6, 38, 40). Meanwhile a dual role for Mss116p in assisting intron folding has been 
proposed in vitro, namely stabilization of the intron core and resolving exonic structures that 
interfere with splicing in vitro (41). 
 
2. Metal Ions and RNA folding 
The earliest event in folding of large multi-domain ribozymes is the transition from the unfolded 
state to a compact structure (42). The transition is significantly preceded by the presence of 
counterions (non-specific electrostatic interactions with ‘condensed’ metal cations) and their 
charge reduction on the negative phosphate backbone with more than 90% (43). This 
condensation around RNA reduces the electrostatic repulsion between the phosphate groups, 
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reduces substantially the radius of gyration (Rg) and as a result drives the collapse of RNA 
(counterion-mediated collapse). The counterion-mediated collapse has been proven with small 
angle X-ray and small angle neutron scattering experiments with various RNAs (43-45). 
Monovalent ions such as Na+ or K+ lack preferred coordination geometry that is different to 
divalent cations such as Mg2+ (46). In the H. marismortui  structure of the large ribosomal subunit 
88 monovalent cations led to the classification of four different monovalent ion categories 
according to their binding sites: a) those that bind to the major groove of RNA helices, b) those 
that bind ribosomal proteins, c) those that bind in the interface of ribosomal protein and RNA and 
d) those that bind RNA motifs (46). The coordination distance for Mg2+ hence, is much smaller 
than e.g. for Na+ (between 2.8 Å  to 3.2 Å) and although it never appears fully hydrated,  Mg2+ it is 
the preferred partner for inner-sphere coordination and as a result for tertiary RNA interactions 
(46). For example, the autocatalytic group II intron ai5γ requires 500mM monovalent ions, 100mM 
Mg2+ and 42°C for optimal folding and splicing in vitro (47). Notably, in vitro conditions are 
typically non-physiological meaning that ion concentration and temperature are considerably 
increased (48). Figure 6 further underlines the utmost importance of metal ions, for the 
Tetrahymena ribozyme where at low Na+ (<150mM) concentration the molecule can easily be 
caught in either a misfolded conformation or intermediate trap. Higher initial Na+ conditions 
obviously allow bypassing these traps and a folding funnel is chosen, in which the native RNA 
conformation is reached directly and more rapidly (3). Metal ions and RNA folding are examined 
in more detailed in chapter ‘Metal Ions and RNA folding’. 
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3. Metabolites  
Furthermore, there are metabolites which promote RNA folding. UREA for example has been 
long known to resolve misfolded RNA conformations at sub-denaturing concentrations (49). It can 
be used for probing stability and unfolding kinetics of proteins (50) and plays a helpful tool for 
exploring RNA folding parameters as well  (51). Folding studies in the presence of urea further 
confirmed that the D135 ai5γ ribozyme, for example, follows a folding pathway devoid of kinetic 
traps (52). However up to now it had been unknown how urea destabilizes RNA. Mason et al. 
(2004) used extensive atom molecular dynamics (MD) simulations to examine the mechanism in 
which urea molecules participate in stacking interaction with purine bases of RNA. The findings 
strongly indicate that destabilization of RNA is caused by a disruption of base-pair interaction 
over multiple hydrogen bonding and formation of stacking interactions of urea with the bases, 
thereby increasing the folding rate of misfolded, kinetically trapped RNA molecules and acting like 
a ‘chemical’ chaperone (53).  
Polyamines are directly affecting gene expression and its role in RNA folding has been illustrated 
for the Tetrahymena ribozyme, for which they induce near-native conformations through structural 
stabilization. The effect increases with charge and decreases with size of the polyamines; thus 
changes in intracellular polyamine concentrations might alter RNA folding pathways. Furthermore 
polyamines enhance the synthesis of key regulators of gene expression at translational level (43). 
In light of these findings, an additional study, in which polyamines were found to enhance the 
synthesis of RpoE and StpA at translational level, further underlines the positive effect of 
polyamines on RNA folding. Polyamines are thought to enhance synthesis of key regulators in 
gene expression at translational level over specific interaction with mRNA regions (54). 
 
In the following chapter we had a closer look on metal ions and how they contribute to RNA 
folding.   
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Metal ions 
Large multi-domain RNA in low salt buffer should have an extended conformation because of 
electrostatic repulsion of its negatively charged sugar-phosphate backbone. Metal ions influence 
RNA folding into a specific tertiary 
structure over thermodynamic and 
structural forces (55). In vivo the most 
relevant metal ions which support RNA 
folding of group I and group II introns 
are K+ and Mg2+ and these therefore 
had been examined extensively (56). 
In the following chapter a short 
overview of three ion environments 
that differ in ion-RNA contacts, the 
degree of ion hydration and to what 
extent ion-environments contribute to 
RNA folding is given (55). Figure 8 (B) illustrates the three general kinds of ion-environments, 
how ions stabilize RNA and why some ions are more effective than others.  
 
1. Ion-RNA Environments 
In the right panel of Figure 8 (B), ions are diffuse (diffuse ions) and only coulomb interaction 
forces are present. Diffuse ions show no contact to RNA surface and their ion hydration shell is 
not perturbed. Ions can be captured by the electrostatic field of RNA; however they are not 
restricted to an exact location in space. The nonlinear Poisson-Boltzmann (NLPB) equation 
provides accurate description and reliable results to calculate energy potentials of ions within 
RNA regions (57). Water-positioned ions (delocalized ions) are illustrated in the middle panel. Still 
Figure 8: Mg2+ ions and the RNA folding problem using tRNA structure 
formation. (A) Monovalent ions: black dots, divalent ions: circles. Two 
transitions are represented; first starting transition from an unfolded 
tRNA state (U). Mg2+ is involved mainly in promoting tertiary structure. 
(B) Illustrating three types of Ion-RNA environments. Left:  direct ion-
RNA contact; middle: water-mediated contact; right: diffuse ions and 
hydration. Ion: small circle; larger circles and shades: RNA backbone 
(Draper 2005).  
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there is a layer of water molecules between RNA and ion but a lot more forces affect and bend 
the RNA backbone. Coulomb forces between RNA and ion, perturbation of hydration layers and 
unsatisfied water molecules cause polarization and charge transfer (55, 58). In the right panel 
chelated ions (site-specific ions) interact with at least two negatively charged RNA groups. The 
electrostatic field surrounding ion and RNA favors a (partially) dehydrated state of the ion 
resulting in a very close ion-RNA environment (55). Notably, interactions between ion and RNA 
structure cannot be simplified to certain classes it is more a concert of all ion ‘classes’ which 
contribute to ion-RNA electrostatic field. 
 
2. The Special Role of Mg2+ 
The special stabilizing effect of Mg2+ on tRNA tertiary structure has been discovered in the 
1970ies (59) and marked a remarkable change in the past decades leading to discovery of new 
RNA functions such as ribozyme catalysis (55). Together with K+(~140mM), Mg2+ (~1mM) has the 
highest concentration of all ions within a living cell and is thus the most relevant ion for 
physiological function (56). It has a smaller ionic radius (0.65 Å) than its monovalent and divalent 
companions (K+ has an ionic radius of 1.3 Å) and with its 10 electrons it is able to bind six ligands 
in octahedral conformation.  Mg2+ is preferred to charge neutralization of RNA structures due to 
its greater charge density and lower entropic cost for localizing ions in a 3D RNA structure (60). 
Nevertheless it is a very difficult task to study Mg2+-RNA interactions with crystallographic 
approaches. The reason is that in crystal structures Mg2+ is difficult to distinguish from Na+ ion 
and water molecules, thus a high structure resolution (<1.5A) is necessary to identify them (56). 
In general Mg2+ forms both outer and inner sphere contacts with RNA and the following chapters 
examine energetic interaction modes in more detail.  
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Outer Sphere Localization 
Preferred outer sphere ligands for Mg2+ ions are anionic phosphate oxygen or electronegative 
atoms of the bases (56). This kind of interaction is often seen in the major groove of A-form 
helices by interacting with the Hoogsteen face of mostly non-canonical base pairs. Guanine 
presents a preferred outer sphere interaction partner (favored atoms are G(N7) and G(O6)) this 
fact has been shown in studies on HIV-1dimer initiation site (61) or in the P4-P6 domain of 
Tetrahymena (at a tandem 5’GG3’/3’UU5’) (62). Outer sphere ions are very mobile in contrast to 
partially dehydrated Mg2+ ions that directly bond to RNA atoms (56). NMR and crystallographic 
studies often present useful data, in particular if no substitutes had been used to demonstrate 
magnesium binding (56).  
 
Inner Sphere  
Partial dehydration and therefore direct bonding to RNA atoms is more likely in non-helical 
regions (56). Neighboring phosphates take a closer position to each other enabling an 
electrostatic environment for Mg2+ to dehydrate its water molecules and chelate to RNA atoms. 
Mg2+ offers charge neutralization to RNA, this can be observed for example in the crystal 
structures of P4-P6 group I intron and 58-nucleotide rRNA (63, 64). A classification of Mg2+ had 
been derived from 116 ions bound to the 50S large ribosomal subunit of Haloarcula marismortui 
by Klein et al. (2004) (46). They observed ten binding modes between Mg2+ and RNA but 
complete dehydration of Mg2+ has not yet been observed (56). The loop E motif of the ribosomal 
RNA has been solved in high resolution (1.5Å) and represents a good model for inner sphere 
coordination. In this structure water molecules and Mg2+ ions could be distinguished by their 
bonding distance (2.1 A for Mg2+ and 2.7 for water).  
Studies on small RNAs or nucleotides, computer modeling (e.g. Poisson-Boltzmann calculations 
or molecular dynamic simulations) together with crystallography and NMR, or more a concert of 
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all approaches provide seminal strategies for providing further insight of Mg2+-RNA binding 
behavior (65) . 
 
DEAD-box Proteins 
In 1989, primary structure alignments of eight different proteins, ranging from E. coli (SrmB) to a 
human antigen (p68), to the eukaryotic initiation factor eIF-4A, lead to the discovery of stunning 
sequence homologies. Regional similarities of these proteins revealed common motifs like the D-
E-A-D box or the S-A-T motif. With the help of additional 
biochemical data they defined a new protein family where 
proteins share several motifs, as well as functions like 
ATPase activity, unwinding of and interaction with nucleic 
acids (66).  
DEAD-box proteins are ubiquitous proteins mediating 
numerous RNA processes and depend on ATP binding and 
hydrolysis for exerting their helicase function. They belong to 
the group of superfamily 2 (SF2) helicases, of which DEAD-box proteins represent the largest 
family (67, 68). Currently, at least 25 yeast DEAD-box proteins, 37 in humans and 5 in E. coli are 
known (69). They perform a diverse set of functions such as they are associated with molecular 
machines, like the ribosome and they play a role in 
nuclear export of mRNA, folding of self-splicing 
introns or even in quality control mechanisms (Figure 
10) (70). Besides their broad range of functions they 
also possess considerable diversity in their 
mechanisms. In principle their central activity is to 
bind and hydrolyze ATP in an ssRNA or dsRNA 
Figure 10: processes in which DEAD-box proteins 
are required. (Linder et al. 2006) 
Figure 9: Unrooted cladogram showing 
different helicase families identified by a 
phylogenetic alignment of all SF1 and 2 
helicases of human, yeast and selected 
viruses. (Fairman-Williams et al. 2010) 
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dependent manner. This biochemical activity is then used by different DEAD-box proteins in 
different ways. They either separate short dsRNA regions to promote structural rearrangements, 
remodel RNP complexes or form highly stable complexes on ssRNA (70). Due to these effects on 
RNA structure DEAD-box proteins play a highly interesting role on RNA folding. In the following 
the main structural features and conserved sequence motifs of DEAD-box proteins are described. 
 
DEAD-box Proteins – Their Structure and Motifs 
What we do know about the biochemical activities of DEAD-box proteins is that they are often 
referred to play a role in unwinding double-stranded RNA. Recent studies suggest that DEAD-box 
proteins unwind RNA duplexes in vivo (71, 72) therefore they are often designated as helicases. 
Such energy related unwinding of double-stranded RNA has been demonstrated but in most 
cases this activity is not processive, meaning they only unwind very short RNA duplexes (69). 
The most likely explanation for the weak action as a helicase would be that they are only required 
for local unwinding of a limited length of dsRNA or rapid dissociation of the protein to allow 
downstream processes (69). There has also been shown that the helicase activity of DEAD-box 
proteins declines with increasing dsRNA length or stability. Some proteins e.g. eIF4A show 
equivalent activity on blunt-ended duplexes and on helices with an 5’ or 3‘ extension (73), 
implying that their function is to generate local strand separation within a helix. This has been as 
well shown for the putative orthologs Mss116p and Ded1p (39, 40, 70). Many other proteins 
though show enhanced unwinding for extended helices. As it is the case for the Neurospora 
crassa protein CYT-19 which promotes folding of mitochondrial group I and II introns and shows 
increased unwinding activity upon extended helices within the highly structured group I introns 
(40, 74). Thus, it has been proposed that extensions provide a site of interaction for the DEAD-
box protein to disrupt nearby RNA structure (70).  
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Solving the structure of yeast translation initiation factor eIF4A (Caruthers et al. 2000) and 
subsequent structural alignments of all annotated sequences revealed at least nine conserved 
motifs that span across the helicase core of the DEAD-box protein family and represent the main 
center for protein activity (66, 75). The helicase core consists of two RecA like domains arranged 
in tandem and connected by a flexible linker. The highest degree of conservation across both 
helicase families had been observed to in motifs that are crucial for nucleotide-triphosphate 
binding and hydrolysis and for residues located within cleft between two RecA-like domains (67). 
More precisely, Motif II (also called Walker B motif) which carries the amino acid sequence D-E-
A-D, together with motif I (Walker A motif), Q-motif and motif VI are required for ATP processing 
(75, 76). Less well characterized are motifs Ia/b, III, IV and V but these have been proposed to be 
involved in binding of the RNA (77). In a recent study, in which they used the Ded1 DEAD-box 
protein as a model, it has been shown that mutations in motif III (also known as S-A-T motif) 
severely reduce the binding affinity for ssRNA, the ability to unwind duplexes and to hydrolyze 
ATP but these mutations have no effect on ATP binding both in vivo and in vitro (78). Thus it has 
been concluded that motif III and the energy from ATP binding is used to coordinate the two 
RecA-like domains, in particular motifs I, II and VI, to create a high-affinity ssRNA binding site 
(78).  
Not many DEAD-box proteins have been biochemically characterized yet compared to the 
enormous amount of proteins present in databases (69). One very critically examined is 
Mss116p. It is still unclear whether Mss116p provides stabilization of the intron structure, 
therefore acting as an RNA cofactor or if it supports RNA folding rather in a chaperone-like 
manner on group I and II introns (6, 38, 40). Therefore we chose the DEAD-box protein Mss116p 
in our studies and the chapter below provides detailed information about Mss116p.  
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The DEAD-box Protein Mss116p – a Group I and Group II Intron Splicing 
Factor 
Mss116p is a member of the DEAD-box protein family and belongs to the mitochondrial splicing 
system of Saccharomyces cerevisiae. It is essential for splicing of 13 group I and group II introns 
in vivo but how Mss116p facilitates splicing remains enigmatic (79-82). Like all DEAD-box 
proteins, Mss116p is able to unwind short RNA duplexes by local strand separation, thus inducing 
conformational changes on RNA and RNP complexes. It contains a conserved helicase core 
consisting of two RecA-like domains linked by a flexible linker and flanked by an N-terminal 
extension (NTE) as well as a α-helical C-terminal extension (CTE) and a basic hydrophilic C-tail 
(Figure 11 and Figure 12) (83). The helicase core of Mss116p encompasses 9 conserved 
sequence motifs and in the closed conformation of the folded protein motifs important for ATP 
and RNA binding are 
brought together 
forming the ‘binding 
cleft’ (83).  
 
 
N-terminal Extension (NTE) 
The NTE is located upstream of domain 1 of the helicase core. This sequence region has been of 
minor interest during the past years and only a few studies on the NTE exist. One presents SAXS 
solution structures for Mss116p, showing that the NTE emerges from domain 1 pointing away 
from RNA binding regions (84). In addition, high-throughput genetic analysis combined with in 
vivo splicing assays showed that mutations in this region (except for regions close its boundary to 
the helicase core) had only minimal effect on Mss116p-promoted intron splicing in vivo. Mss116p 
mutants completely lacking the NTE function nearly as efficient as the w/t protein in promoting 
Figure 11: Schematic of Mss116p domains and conserved motifs. Mt: mitochondrial 
localization sequence, NTE: N-terminal extension, CTE: C-terminal extension. (Mohr et 
al. 2011) 
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ai5γ group II intron splicing in 
vitro (84). Taken together,  it 
has been suggested that the 
NTE is a flexible attachment to 
the helicase core which has 
only minor effect on Mss116p’s 
role as splicing factor and does 
not alter folding behavior of the 
protein (83).  
 
Helicase Core 
The helicase core of Mss116p 
is a highly conserved region 
and very similar to other DEAD 
box proteins like CYT-19, Vasa, 
DDX19 or eIF4AIII (85). It 
comprises 9 conserved motifs that span across the two RecA-like domains which are connected 
via a flexible linker region. Mss116p had been successfully crystallized in complex with a 10mer 
poly-U RNA oligonucleotide and an ATP analog (AMP-PNP) in 2009 with a resolution of 1.9 Å. 
This crystal structure shows the entire closed-state helicase core and C-terminal extension (CTE) 
of the protein. In an open conformation the RecA-like domains are separated and moveable over 
the linker. The compact closed state is induced upon binding of ATP and RNA. When substrates 
are bound the conserved motifs are brought together in close proximity and are the main 
interaction points for ATP and RNA binding (85). Each motif participates in a certain manner to 
RNA and ATP binding and below we summarized their specific functions.  
Figure 12: structure of Mss116p with ssRNA and AMP-PNP showing two 
different views of domains and motifs. (Del Campo 2009) 
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Motif Q has a specific function in ATP binding; residue F126 stacks with the adenine base (86). 
High-throughput genetic identification studies support this, as only two functional variants, which 
provide adequate hydrophobic residues this position, were found (67, 87).  Motif II b (GG) and 
motif Ic (TPGRxxD) interact with the bound 
ssRNA at the bending point in the helicase core 
(83). Motif Ic is thought to further exaggerate 
RNA bending by H-bonding of the G244 amino 
group with the 2’ oxygen of U6 of the ssRNA 
oligonucleotide (83). Motif II (DEAD) and motif 
VI are the main constituents of the ATPase 
active site and both are highly conserved (67). 
Motif III (SAT) is involved in a series of 
interactions across domain 1 and 2 of the 
helicase core. Through mutational analysis of 
the yeast DEAD-box protein Ded1p showed 
that mutations in motif III inhibited unwinding 
and weakened ATP-dependent ssRNA binding, 
resulting in a decreased ATP hydrolysis (78).  
The crystal structure of Mss116p shows eight 
amino acids (R190, T242, R245, D248, D280, 
K384, R415 and T433) whose side chains directly 
contact with poly U RNA (Figure 13) (86). 
Surprisingly, only two of the eight showed strong 
conservation in the high-throughput genetic identification (R415 and T433) (83). The side chains 
of the two conserved residues are supposed to be essential for Mss116p function. Two other 
Figure 13: Mss116p residues that contacting U10 RNA. 
(Del Campo 2009) 
Figure 14: showing contacts between U10 RNA and 
Mss116p residues. Blue: H-bonds; light-grey: ionic 
contacts; black: hydrophobic contacts; red: water contacts; 
solid and clashed lines: side and main-chain interactions; 
double rectangles: base stacking; blue bases: positive 
potential, red bases: negative potential. (Del Campo 2009) 
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residues (R190 and R245) make both side-chain and main-chain interaction with U10 RNA but 
selected variants (mostly hydrophobic) replacing them indicates that their side-chain contacts are 
not essential. For R245 a mutant was tested (R245A) showing only main-chain contacts which 
slowed mutant growth indicating that the side-chain contact enhances Mss116p function. Similar 
results had been shown for the R190A mutant (83). All four residues are very conserved and 
crystal structures of Vasa and eIF4AIII show the same contacts of these amino acids with ssRNA 
substrate (83, 88).  
 
 C-terminal Extension (CTE) and Basic Tail (C-tail) 
The crystal structure of Mss116p consisting of the helicase core and a structured CTE (truncated 
basic C-tail; Mss116p/∆598-664) showed that the CTE interacts with RNA binding side of domain 
2, thereby stabilizing the core and introducing a 
second bend in the RNA chain acting like a ‘crimp’ 
(Figure 15) (86). Also, the CTE was found to 
enhance efficiency of promoting group II intron self-
splicing in vitro (6, 38). Also, comparing the 
sequence and proteolysis pattern of Mss116p and 
CYT-19 revealed that Cyt19 has a helicase core, 
CTE and basic tail similar to Mss116p. For both 
DEAD-box proteins the C-tail enhances RNA binding 
and ability to promote intron splicing (89, 90). This interaction stabilizes binding of the helicase 
core to structured RNAs, giving the protein the ability to sample neighboring dsRNA regions while 
remaining near substrate. However, the flexibility of the C-tail relative to the helicase core has not 
been determined for any DEAD-box protein. Mallam et al. used SAXS to obtain structures of 
Mss116p and CYT-19 in open and closed states. Their results indicate the location of NTE and C-
Figure 15: Panel (A): Mss116p tethering range of 
the C-tail, ~100 Å is the lower limit for space over 
which the C-tail can bind nucleic acid. Panel (B): 
Model of Mss116p binding to Tetrahymena group I 
intron showing that anchored over its C-tail 
Mss116p is able to act at various over a wide range 
of the substrate. (Mallam et al. 2011) 
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tail and visualize the conformational changes upon RNA and ATP binding. The SAXS data further  
revealed a mechanism in which the C-tail is flexibly tethered the core of large RNA substrates 
(84). Notably, the afore mentioned crystal structure of Mss116p lacked a C-tail and the NTE; thus 
it remained unclear how these substructures contribute to Mss116p function (84).  
Despite the amount of information present for Mss116p there are unanswered questions on 
Mss116p functions as group I and group II intron splicing factor. It still has to be addressed which 
mechanism DEAD-box proteins apply to bind double stranded RNA substrates and to trigger ATP 
binding and hydrolysis coupled with RNA binding and release. It is as well unknown whether 
regions on the opposite strand within the helicase core are responsible for strand sequestration, 
thereby contributing to RNA unwinding and what nature of mechanism causes local unwinding. 
Furthermore there is need to answer  the function of ancillary domains and  partner proteins (83).  
 
In our study we want to offer additional structural information about Mss116p binding to group II 
introns and as a model system we chose the autocatalytic ai5γ group II intron.  
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Group II introns 
Group II introns are self-splicing RNAs, meaning that they catalyze their own excision, in most 
case with the help of proteins in vivo (91).  They can be found in plants, fungi, yeast and bacteria 
(92, 93) where splicing is essential for genes that are involved in metabolism pathways (94). 
Many group II introns do not contain coding regions, though many are mobile elements related to 
retro-transposons (95) and therefore encode a reverse transcriptase designated as maturase. 
This protein facilitates the insertion of their cognate group II intron into DNA and RNA targets  
through reverse–splicing (96). The open reading frame for such a maturases is located within 
intron domain 4 of group II introns, like Lactococcus lactis LI.LtrB intron (91, 97) or the yeast mt 
introns ai1 and ai2 (98). Aside from their reverse transcriptase activity maturase, also called  
intron-encoded proteins (IEP), show DNA endonuclease activity guaranteeing splicing and intron 
mobility (97, 99). Through their ability to hop into new genomic locations it is believed that group II 
introns played a major role in the spreading of non-
coding RNAs and that they still continue shaping the 
evolution of host genomes (100). 
 
Group II Intron Splicing 
The group II intron splicing reaction requires a 
conserved RNA architecture formed by six domains 
coming together in space through the formation of long-
range tertiary interactions (101, 102). Notably, only a few 
nucleotides are conserved between group II introns and 
phylogenetic co-variations are rare as well (103). This 
secondary structure organization is shared by the three 
major group II intron families that are classified 
Figure 16: The three classes of group II introns 
classified according to how exons are bound by 
the ribozyme. (Michel et al. 2009) 
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according to how exons are bound and positioned (Figure 16) and by their differences in the 
structural composition of subdomains (104).  
 
The six domains with various helical stems contain motifs important for intron assembly and 
catalysis (Figure 17) (105). The catalytic core and architecture of introns are now well-defined 
and 3D models of IIA and IIB have been created (106, 107) and with the crystal structure of a IIC 
intron recently the active site of 
a group II intron has been 
solved (108). The mechanism of 
self-splicing and related 
reactions by the active sites has 
been examined extensively and 
make it an interesting subject 
for studying RNA folding and 
catalysis (94). Mechanistic 
parallels with the eukaryotic spliceosome had been observed and led to speculations that group II 
introns are evolutionary predecessors and simple models of the spliceosomal active site. The ai5γ 
group II B intron is the fifth intron in the COX1 gene of yeast mitochondria (109) and has been 
widely used as a model system. In the following we describe splicing reactions that have been 
observed during in vitro self-splicing of the ai5γ group II intron (Figure 18). 
  
Figure 17: Schematic of group II intron secondary structure with molecular 
features involved in the active site. EBS: exon-binding sites; IBS: intron-
binding sites. Conserved components are highlighted in green. Note that MGC 
(M= A or C) sequence within the catalytic triad forms a triple helix together 
with J2/3. (Keating et al. 2010) 
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Branching Pathway of Splicing 
 The most prominent self-splicing pathway in group II introns is the branching one involving a two-
step trans-esterification reaction. The first step is carried out by the nucleophilic 2’-OH group of 
the branch point adenosine located in the intron domain D6 that attacks the 5’splice site. This 
results in a release of the upstream exon and the formation of an intron-3’-exon intermediate. In 
the second step of splicing, the 3’-OH group of the 5’exon performs a nucleophilic attack at the 3’ 
splice site thereby releasing the intron in 
a lariat form and in the ligation of the 
exons (Panel A). This mechanism is quite 
similar to the spliceosomal intron splicing 
and has therefore significantly influenced 
the development of group II intron 
reactivity and structure models (94).   
 
Hydrolytic Pathway of Splicing 
In parallel to the branching reaction 
splicing can occur by water or hydroxide 
ions acting as a nucleophile, as depicted 
in  Figure 18 B) (94). An external 2’-OH 
group or water molecule herein carries out site-specific phosphodiester hydrolysis reaction at the 
5’-splice site, resulting in a released 5’exon, which attacks the 3’splice site in the second step. 
Eventually this result in ligated exons and the intron is excised in a linear form, which is the only 
difference to branch-point splicing. A special role for the hydrolytic pathway has been suggested 
in vivo inasmuch as it may  represent a mechanism for regulating  the reactive lariat intron 
Figure 18: three types of splicing reactions observed during in 
vitro self-splicing of ai5γ group II intron. Panel A illustrating 
branch-point splicing; Panel B hydrolytic splicing; Panel C shows 
spliced-exon reopening. The first step is the rate-limiting step 
and step 2 happens very fast. (Daniels et al. 1996) 
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species, as these are potentially deleterious because of their ability to reverse-splice and 
reintegrate into other genomic regions (94, 110, 111).  
 
Spliced-Exon Reopening (SER) 
During in vitro splicing of ai5γ free 5’ and 3’ exons can be observed (Panel C) caused by so called 
spliced-exon reopening (SER). This reaction had been observed under several different splicing 
conditions regardless of the branching or hydrolysis pathways. SER can take place immediately 
after splicing.  The two joined exons are hydrolyzed by the intron RNA acting like a ribozyme (94, 
112). This cleavage reaction was shown to be a mechanistic analog of the first step of reverse 
splicing (113). 
  
Reverse Splicing 
Lariat and linear introns are able to perform the reverse of the splicing reaction. Generally it was 
believed that only lariat introns perform this mechanism but a recent study on the ai5γ group II 
intron showed that linear introns is able to reverse splice rapidly and with high precision as well 
(110, 114). In addition, it has been observed that reverse splicing by lariat intron is surprisingly 
unfavorable and that the linear intron was not observed to undergo both steps of reverse splicing 
suggesting a restricted mobility mechanism (114).  
 
Circle Formation 
Circle formation during group II intron splicing was first discovered in 1984 by Osiewcaz and 
Esser. At the beginning it was believed that circles are more likely to be produced than lariat 
introns (115). Interestingly, when RNA circles are observed in a living cell, DNA circles are 
detectable as well (116). In Podospora anserina the amount of circular intron DNA had been 
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found to be increased in senescent cells (115, 117). However, it is suggested that circular introns 
represent a conserved side reaction of group II intron splicing in vivo with unknown function.  
 
Structural Group II Intron Domains 
 
Since their discovery the structure, 
folding pathway and function of 
group II introns has been studied 
biochemically. After ~ 30 years the 
crystal structure of the 
Oceanobacillus iheyensis (Toor et 
al 2008), made it possible to obtain 
profound insights into the group II 
intron architecture. The group II C 
intron is ~ 1/3  smaller and has 
been less  extensively studied than 
the introns belonging to the phylogenetic families IIA and IIB introns but they share the same 
domain structure (118). Despite these differences, numerous of the tertiary contacts identified 
phylogenetically or biochemically in the IIA or IIB introns were observed in the Oi. group IIC intron 
as well. In brief, due to the presence of most predicted interactions in the crystal structure there is 
little doubt left that the presented structure is that of a functional molecule (118). In the following 
an overview of the structural organization and the intricate architecture of group II introns is given. 
While there is little sequence conservation, the six domains that radiate from the central wheel, 
are structurally highly conserved for group II introns (Figure 19). 
 
Figure 19: Ai5γ group II intron sequence map. EBS/IBS: exon/intron 
binding sites; Greek letters indicate long-range tertiary contacts; yellow: 
folding control element. (Liebeg et al. 2010).  
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Domain 1 (D1) 
D1 is by far the largest of all domains (119), folds autonomously and serves as a scaffold for 
docking of the other domains (120). Together with D5 it is indispensable for chemical catalysis 
and represents  the minimal structure capable of performing activity (121). D1 recognizes the 5’-
exon through exonic substrate recognition sites (EBS1/2) and contains elements that recognize 
the 3’-exon via the δ-δ’ interaction (115, 122). Furthermore, D1 contains three essential long-
range tertiary contacts between D1 and the ‘catalytic center’ which had been identified by 
phylogenetic analysis and nucleotide analog interference suppression (NAIS)(123). The tertiary 
interaction ζ-ζ’ and κ-κ’ had been shown to be important for D5 docking (103) and λ-λ’ interaction 
positions D5 in close proximity to the 5’-splice site and is directly involved in catalysis (123). 
Phylogenetic analysis has shown that the interaction ε-ε’ is also important for the catalytic 
function of the intron (124). The α-α’ contact has been implicated in facilitating binding of 5’-exon 
and has been shown to play an important role in the folding process as well (125, 126). The 
tetraloop-receptor interaction θ-θ’ is suggested to play a role in structural stabilization of the intron 
core and in recruiting the catalytic effector D3 together with J2/3 to the active site (127, 128). In a 
recent study it was shown that subdomain IC1 within D1 might serve as a first-step-specific RNA 
receptor for the branchpoint-carrying D6 (129). 
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Domain 2 (D2) 
D2 lacks phylogenetic conservation, but has been shown to play an important function in intron 
activity and tertiary structure stabilization together with D3 (128). It forms long-range interactions 
with D1 and D6 (θ-θ’ and η-η’, respectively) (127, 130). NAIM (nucleotide analog interference 
mapping) experiments suggest an interaction between D2 stem and D3 that builds on the θ-θ’ 
interaction, suggesting that these two components are key elements of group II intron core and 
for active-site assembly (128).The η-η’ interaction is suggested to serve as a switch between the 
two steps of splicing (130). However, up to now not much information about D2 serving as a 
conformational switch for the second splicing step is available and further experiments are 
required to provide more information about the functionality of D2 (115). 
 
Domain 3 (D3) 
D3 is known as the catalytic effector (131), however it is not strictly required for catalysis but 
enhances group II intron ribozyme activity (128, 132). D3 is suggested to dock via multiple tertiary 
interactions and high affinity (133). However, not much phylogenetic co-variation between D3 and 
other domains could be observed, suggesting that the tertiary contacts are not involved in 
Watson-Crick base pairing or tetraloop-receptor interactions (115). The tertiary contact µ-µ’ 
between D3 and D5 has been identified by NAIS experiments and was shown to be important for 
catalysis (134). Nucleotides within the internal bulge are the most conserved residues within D3 
and NAIM studies suggest that these are involved in tertiary contacts and might be part of a 
larger structural motif (134).  
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Domain 4 (D4) 
D4 does not contribute to self-splicing but contains the ORF encoding the maturase involved in 
intron mobility in vivo in some group II introns (121, 135). It has been suggested that D4 acts as a 
protein-binding platform due to its location on the surface of the intron (115). 
 
Domain 5 (D5) 
Domain 5 is the phylogenetically most conserved domain and trans-splicing analysis 
demonstrated that this domain is the most important component for catalysis (136, 137). 
Mutational analysis showed that certain important regions, including ζ-ζ’, κ-κ’ and λ-λ’, are 
essential for linking Domain 5 to other domains (131). As a matter of fact this domain has been 
most extensively studied and two important themes emerged. First, a set of three nucleotides, so 
called ‘catalytic triad’ with the conserved AGC sequence, in the basal stem of D5 together with 
nucleotides located in the D5 bulge are essential for ribozyme catalysis (138, 139). The Oi. 
crystal structure reveals this interaction in more detail, where the J2/3 element is composed of 
three nucleotides A287, G288 and C289. Nucleotide G and C emerge into the major groove of D5 
and forms a stacked triple array to the nucleotides of the catalytic triad located in D5 forming a 
completely merged triple helix that brings together catalytically crucial residues of the intron 
(catalytic triplex) (108).  Second, D5 shares stunning sequence and structure similarity to U6 
small nuclear RNA  (snRNA) of the spliceosome involved in nuclear pre-mRNA splicing (140-
142). Therefore D5 represents an important link between group II introns and the spliceosomal 
machinery (143). 
 
Domain 6 (D6) 
D6 contains the conserved bulged branch-point adenosine that is essential for the branching 
pathway of group II intron splicing (144). D6 is missing in most crystal structures but comparative 
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sequence analysis, kinetic analysis, modeling and oligonucleotide anchoring point to subdomain 
IC1 (ι-ι’ interaction) and subdomain II A (η-η’ interaction which positions D6 for exon ligation 
(130)) to be the first step RNA receptor to be the successively bound location of D6 and has been 
shown to be essential for the efficiency of lariat formation  (129). In the model of Li et al. D6 and 
subdomain IC1 are optimally tethered over a single nucleotide (129) where in another recently 
proposed arrangement a coordination loop serves as a receptor for branch-point interaction 
(145). The recently published sketch by Pyle et al. displays a model of possible first-step 
conformation in between the two previous models (146) but all three models clearly differ and a 
major rotation of D6 is necessary after branching step to dock to D2 (second-step receptor) (129). 
It is as well highly interesting to study the atomic environment around the branch point and it has 
to be kept in mind that tinkering with RNA architecture might alter the ribozymes function and 
further studies are necessary to find the link between spliceosomal and group II intron splicing. 
 
Metal Ions Involved in the Ai5γ Folding Pathway 
Magnesium ions are essential for the large ai5γ ribozyme to fold into the active conformation and 
for catalysis (147). A powerful technique, which provides information about location of metal ion 
binding sites within folded RNAs, is the metal ion-induced cleavage assay (147). In early 
approaches Pb2+ (148) or Fe2+ ions (149) served for probing for divalent ion binding sites, but the 
main disadvantage is that their geometry differs from Mg2+ or these are in need of non-
physiological conditions (147). As a consequence, lanthanide(III) ions, particularly Tb3+ ions have 
more recently been applied for detecting binding pockets (147). The radius of hexa-coordinated 
Tb3+ with 0.92 Å is close to that of Mg2+ with 0.72 Å (150), and has the same coordination 
geometry for ligands (151).  
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Figure 20: Ai5γ terbium and magnesium cleavage sites superimposed on a 
secondary structure representation. (Sigel et al. 2000) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sigel et al. 2000 applied the Tb3+-induced cleavage assay to the ai5γ ribozyme to map the metal 
ion binding pockets in the intron in its native, active conformation. It has been observed is that 
most Mg2+ binding sites are close to the ribozyme active site in line with the fact that group II 
introns are metallo-enzymes (Figure 20). In fact, in the crystal structure of the Oi. group IIC intron 
metal ions within the active site have been observed as well (108). Two metal ions (M1 and M2) 
are bound by the catalytic triad and the bulge within D5 which results in the formation of a 
negatively charged pocket (108). The crystal structure provides further evidence assigning the 
two metal ions as catalytic metal ions showing that they reside on the surface of D5, with a 
distance of 3.9 Å between M1 and M2, which is the ideal distance for metal ion reaction of group I 
intron and protein phosphate-transferases (152) and thus are accessible for both splice sites (5’ 
and 3’) (Figure 21) (108). Further bindings sites were found close to nucleotides near or within the 
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EBS1, the Jd’’/d’’’ motif, the λ and ε’ interaction site and close to the branch site (147). Some 
prominent cation binding sites were detected close to α-α’, β-β’ interaction sites, the three-way 
junction within D1 and close to non-conserved regions in D3 and D4 (147). These are likely to 
play an important structural role, in coordinating the interaction of substructures. 
The identified metal ion binding sites correlate well with those regions that have previously been 
observed to become protected from hydroxyl radical cleavage after folding to the native state 
(108). In other words, close packing of the backbone at these regions due to Mg2+ charge 
neutralization renders these elements inaccessible to the attack by OH radicals. (153). 
Interestingly, metal ion binding pockets near the κ-ζ element could be only detect during ai5γ 
intron collapse and were not observed in the 
native state (148). This could be explained by 
the fact that metal ions during the collapsed 
state are detectable in the minor groove of 
ribozyme structure and that Tb3+ cleavage 
assays need a perfect Tb3+ location to the 2’-
OH ribose which might not be present any 
more in the native state (154). Sigel et al. 
pointed out a another slight drawback of 
detecting metal ion binding sites via 
lanthanides; it is quite likely that additional important binding sites (G-C rich duplexes such as the 
basal stem of D5 or the tandem GU wobble pairs (155)) remain undetected because of RNA 
hydrolysis caused by metal hydroxides or because they are located in the major groove (147).  
 
  
Figure 21: Schematic of catalytic triplex structure. 
Hydrogen bonds are shown as dashed yellow lines; 
Conserved linker element J2/3 (blue) forms base triple 
interaction with catalytic triad (orange) and stacks beneath 
the bulge (red) to position the binuclear metal cluster 
(orange spheres) for splicing reaction. (Toor et al. 2008) 
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The Ai5γ Group II Intron Folding Pathway In Vitro 
Despite its size (0.9kb) and multi-domain organization the ai5γ ribozyme appears a smooth and 
autonomous folding pathway in vitro. At high magnesium and monovalent ion concentrations the 
ai5γ ribozyme folds slowly to the native state, whereby its folding pathway is interspersed by two 
over on-pathway intermediates (5, 154, 
156). Kinetic and equilibrium folding studies 
on the ai5γ D135 and D1356 ribozyme 
under in vitro and near-physiological 
conditions (Figure 23) provided important 
insight into the ai5γ folding pathway and 
showed that transition to the near-native 
state is direct, autonomously and lacking 
kinetic traps (115, 154).  
 
In the first place D1 of the D135 
ribozyme collapses slowly to a 
transient intermediate and forms a 
highly structured and compact 
scaffold onto which D5 and D3 
rapidly dock into preassembled 
binding sites (122). Very important 
during the slow collapse is the rate-
limiting formation of the κ−ζ element 
within D1, which offers a docking site for D5 and was found to induce the collapse (154). Folding 
of the κ−ζ element is specifically associated with metal ion binding events that lead to the tertiary 
Figure 22: Secondary structure and long-range tertiary contacts 
within ai5γ intron. Small Greek letters: long-range contacts; 
Greek capital letters: Proximity contacts detected by UV 
crosslinking; green: folding control element. (Fedorova and 
Zingler 2007). 
Figure 23: D135 minimal folding pathway. (U) Unfolded; (I) Extended 
intermediate state; (F) Folded intermediate state; (N) Native 
conformation. The addition of Mss116p and ATP enhances native 
intron formation. (Fedorova et. al 2010) 
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collapse (5, 126, 154). The compact substructure is then locked by intra-domain interactions 
(α−α’, β−β’), allowing subsequent docking of D3, D5 and D6, thereby completing intron assembly 
(122, 156). Recent folding single molecule FRET (smFRET) studies on the folding pathway of the 
D1356 ribozyme under near-physiological conditions revealed a novel intermediate (F) during 
transition from the extended intermediate (I) to native state (N) (Figure 23)(157). It is worth 
mentioning that studies on the D135 and D1356 constructs lack other domains and the flanking 
exons, therefore possibly presenting a simplified folding event (156). Stabilization of an early 
folding intermediate by intron-associated proteins is likely to play the most important role in 
promoting productive group II intron assembly (105). 
 
Protein Facilitated Group II Intron Folding 
Proteins can facilitate folding of RNAs, like group II introns via several mechanisms. First they 
facilitate the collapse of large RNA by relieving unfavorable charge-charge interactions when 
RNA compacts (105). Alternatively, proteins interact non-specifically with RNA and are able to 
unfold misfolded RNAs allowing RNA to refold (27, 32). This mechanism is considered as RNA 
chaperone activity (27). Most molecular chaperones , which facilitate folding of proteins, are ATP-
dependent (158), while RNA chaperones act in an ATP-independent manner facilitating RNA 
folding by resolving kinetic traps (48, 159, 160). Third proteins could stabilize correctly folded 
RNA in two ways. Either they may bind a substructure of large RNA to form a platform for proper 
RNA assembly (161) or they bind and stabilize the correctly folded form (tertiary-structure 
capture) (48, 162) or over solving misfolded RNA conformations thereby acting like RNA 
helicases. A very prominent DEAD-box helicase, Mss116p is important for folding of all group I 
and group II introns in vivo (79) and facilitates splicing in presence of ADP or ATP (6). Mss116p 
like other helicases (CYT-19 or Ded1) offers a non-conserved C-terminal domain that is positively 
charged (6) suggesting that it could facilitate intron collapse by relieving unfavorable charge-
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charge interactions (102). The ai5γ group II intron self-splices under high-salt conditions 
(~100mM Mg2+, 0.5M monovalent salts and 42°C), but efficient splicing in vivo and under near 
physiological conditions in vitro requires Mss116p and ATP (Figure 23) (82). 
 
Possible Mechanism of Mss116p on Ai5γ Group II Intron Structure 
Mss116p is essential for splicing of all, group I and group II, yeast mitochondrial introns which are 
nearly all located in the COX1 and COB1  genes (one group I intron is found in the large 
ribosomal RNA) (38, 79). Mss116p was observed to reduce the Mg2+ concentration necessary for 
proper intron folding over offering unwinding and annealing activity in vitro (6, 38, 39, 157). While 
Mss116p’s ATPase activity is essential to promote intron splicing both in vitro and in a living cell 
(38, 79), it is not clear whether its unwinding activity is also required for the intron folding process 
(40). Therefore two distinct models for Mss116p facilitating RNA folding have emerged where in 
the first it might function as a splicing factor by acting in a RNA chaperone-like manner (6, 40) 
and in the second it offers stability to the intron RNA (38). Recent DEAD-box protein-facilitated 
kinetic folding studies showed that Mss116p directly stimulates Sc. ai5γ folding by accelerating 
the collapse to the near-native state (U    I) in vitro (157). It has been observed that this reaction 
is highly ATP-dependent, where ATP is required for protein turnover, thereby stabilizing an early 
folding intermediate (Figure 24, Panel C) (157). Interestingly, Mss116p is not required to stabilize 
the native state of the intron. Unwinding of the long exon sequences of ai5γ in vitro is essential for 
exon unfolding, but not for intron unfolding (41) thereby showing unwinding activity as well as 
acting like a stabilizing cofactor. Mss116p contains conserved helicase motifs which are located 
on the N-terminal domain and an argninine-rich, positively charged C-terminus which is not 
shared by all DEAD-box protein (90). Cyt19 and Ded1 are able to functionally substitute for 
Mss116p in vitro and in vivo (38, 86) and carry as well a positively charged C-terminus which 
might facilitates intron collapse by relieving unfavorable charge-charge interactions (102). DEAD-
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box proteins are prominent as helicases and the mechanism appears to be related to RNA 
chaperones (154). However, Mss116p requires ATP as an external energy source to unwind local 
strand regions (69, 163-166). Finding that Mss116p is also able to stabilize RNA structures 
broadens the known repertoire of function suggesting multiple roles that shape the architecture 
and folding landscape of RNA complexes.  
 
 
 
 
  
Figure 24: In vitro folding of the Sc. ai5γ intron. Folding pathways illustrated at (A) non-
physiological conditions, (B) near-physiological conditions and (C) in the presence of 
Mss116p. The cylinders represent intron elements and were sketched: DI (dark gray), 
DIII (light gray) and DV (black), and DII and DIV (white) and DVI and the exons 
(omitted). Mss116p is represented as ellipse. The unfolded, compact intermediate, 
folded and native states are abbreviated as U, Ic, F and N, respectively. The F state 
has not been studied at near-physiological conditions or in the presence of Mss116p. 
This conformation is hypothetical model and was therefore put in brackets. 
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The Scientific Aim of the Project 
The aim of the project is to detect metal ion binding sites within the ai5γ group II intron in vitro in 
the presence and absence of the DEAD-box protein Mss116p. As Mss116p significantly lowers 
magnesium requirements for folding of ai5γ in vitro (6, 38) and since it does not alter the metal ion 
binding sites in vivo (Wildauer and Waldsich, unpublished), I wanted to monitor whether Mss116p 
influences the formation of metal ion binding pockets in the in the collapsed and native states of 
the ai5γ intron in vitro at near-physiological conditions. In other words, does Mss116p take over 
the role of some magnesium ions during compaction of the ai5γ intron? To accomplish this task, 
recombinant Mss116p had to be purified from E. coli and subsequently its functionality has to be 
confirmed by means of an ATPase assay and an in vitro splicing assay. The last milestone is to 
establish and adapt the powerful technique of a Tb3+-induced cleavage assay to detect 
magnesium binding sites within the ai5γ intron in vitro. 
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Materials 
 
1. Strains  
 
Competent Cell Kit 
The Rosetta 2(DE3)pLysS Singles Competent Cells (Novagen; Cat. No.71401-3) kit uses an E. 
coli strain which is a BL21 derivative and supplies tRNAs for rare codons. This makes the cell kit 
suitable for eukaryotic protein expression. The cells carry a plasmid with chloramphenicol-
resistance and carrying the tRNA genes, which can be induced over T7 lysozyme and regulation 
of lac operon control elements (novagen.com). We used IPTG, a lactose derivate and inducer of 
the lac operon over binding to the lac repressor.  It cannot be metabolized by E. coli and therefore 
concentration within the cell remains the same. As a result genes underlying the lac operon are 
expressed and level of expression is regulated over IPTG concentration. Genotype: F- ompT 
hsdSB(RB- mB-) gal dcm λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) pLysSRARE (CamR) 
(opennetware.org).  
 
DH5α Competent Cells 
DH5α cells were made competent over CaCl2 /PIPES method (by Nora Sachsenmaier). In brief 
cells were grown to an OD600nm of 0.5 – 0.7 with an overnight culture. Afterwards cells were put 
on ice for 15 min, harvested and resuspended in ½ x Vol. cold 100mM CaCl2 solution and put on 
ice for 5 min. Cells were again harvested and resuspended in 1/10 x Vol. cold 100mM CaCl2 and 
put on ice for 90 min. After a spin down cells were resuspended in 1/10 x Vol. ice cold 100mM 
PIPES and put on ice for 2 min. After another centrifugation cells were resuspended in 1/12.5 x 
Vol. 100mM CaCl2 / 15% (v/v) glycerol, split in aliquots and immediately stored at -80°C.  
This E. coli host strain lacks endonuclease A (endA-) which increases the yield of plasmid DNA 
produced and lowers the production of nicked plasmid DNA (167). Genotype: F- endA1 glnV44 
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thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
(opennetware.org).  
 
100mM CaCl2 –PIPES-glycerol pH 7.0 
 7.3 g CaCl2 
 1.73 g PIPES  
 75 ml glycerol 
PIPES won´t dissolve until pH is adjusted to 7.0. Adjust pH with NaOH and fill up to 500ml with 
ddH20. Autoclave buffer and store at 4°C.  
 
100mM CaCl2  
 7.3 g CaCl2 
Fill up to 500ml with ddH20, autoclave it and store at room temperature. 
 
100mM PIPES pH 7.0 
 15.11 g PIPES 
PIPES won´t dissolve until pH is adjusted to 7.0. Adjust pH with NaOH and fill up to 500ml with 
ddH20. Autoclave buffer and store at 4°C.  
 
 
A detailed list of genotype nomenclature and abbreviations can be found at 
http://openwetware.org/wiki/E._coli_genotypes. 
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2. Plasmids 
 
pAS02 
In this plasmid the wild type (w/t) Mss116p sequence lacking the mitochondrial localization signal 
was subcloned into the parental vector pET SUMO TA 
cloning site (Invitrogen). pAS02 encodes Mss116p without 
MLS  (Mss116p/∆MLS, 85.2 kDa). The parental vector carries 
a T7 promoter which allows IPTG inducible expression of 
recombinant Mss116p in E. coli. After purification via the 6x 
HIS tag the SUMO protease is able to cleave off the N-
terminal tag (SUMO and 6 x HIS tag ~ 13 kDa, see Figure 
25), producing untagged, native Mss116p/∆MLS protein. The 
plasmid also carries a kanamycin resistance gene. The 
plasmid was a generous gift from Anna Marie Pyle (Yale University). 
 
pEL85 
The full length group II intron Sc. ai5γ D123456 
(841 nt) without exons was subcloned into the 
parental vector pBS-∆T7. This vector has a 
deleted T7 RNA polymerase promoter region. 
The plasmid carries an ampicillin resistance 
gene. We also obtained the plasmid from Anna 
Marie Pyle (Yale University).  
 
  
Figure 25: pAS02 plasmid map 
The figure shows a plasmid map of the 
parental vector pET SUMO which carries 
the full length Mss116p (∆MLS) sequence 
(invitrogen.com). 
Figure 26: pBluescript II SK- phagemid vector map. The 
full length ai5γ group II intron sequence was subcloned 
into pBS-∆T7.  
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pJD20 
In this plasmid the full length group II intron Sc. ai5γ D123456 with part of its flanking exons (1139 
nt) was subcloned into the parental vector (Stratagene). The insert is flanked by SacI and HindIII  
restriction sites and carries an ampicillin resistance gene (136). The plasmid was a kind gift from 
Philip S. Perlman.  
 
3. Oligonucleotide Specification and Quantification 
 
Overview 
 
Assay Name  Sequence (5’ to 3’) Length Tm  
   (mere) (°C) 
 
Unwinding assay TS12 GCCUCGCUGCCG 12 44 
 BS12 CGGCAGCGAGGC 12 44 
 TS12-cold GCCTCGCTGCCGAAAAAA 18 56 
 
ATPase Assay BS12 CGGCAGCGAGGC 12 44 
 
RT primers Sc 82 TGTTACCATTTTAATACACTTG 22 56 
Sc 160 GTTCCTTCATCTTTTTTTTATAA 23 58  
Sc 234 GTTTTCAATTAGTGGTGTAAG 21 56  
Sc 312 TTCCAATACATAACATCAACC 21 56 
Sc 375 GTAAATATCTAACTTAGCTCTC 22 58  
Sc 440 TTGGTATTATTATTATTTTTTATTATTA 28 60 
Sc 520 TATTTCTTAATCCAATAATTATTTATA 27 60 
Sc 588 GCATTAGCTTTTTATACAATC 21 58 
Sc 656 CACCTATAGTATAAGTTAGCAG 22 58  
Sc 682 ATAATAATAATATATATATAAATAAA 
 GATAGGC 33 53 
Sc 754 ATTTATCAGTTATATATAAACCTCC 25 62 
Sc 805 CGGCTCACGCAATATC 16 58  
Sc 866 CCCGATAGGTAGACCTTTAC 20 60 
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Figure 27: Sc primer binding sites in the ai5γ group II intron. The figure shows a 2D structure map of ai5γ intron with its Sc 
primer binding sites highlighted in different colors. Roman numerals: intron domains.  Lower case letters: subdomains; 
greek letters: tertiary intron interactions; wavy lines indicate truncated Domain II which is separately presented in the grey 
box. EBS: exon binding sites; IBS: intron binding sites. 
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4. Extinction Coefficients  
 
For short sequences we calculated the wavelength dependent extinction coefficient ε [L•mol-1•cm-
1] over the following equation (nucleotide extinction coefficients and equation taken from 
www.operon.com  and www.owczarzy.net). The calculation over the below stated equation is one 
of the most accurate methods to determine ε. 
𝜀260 =  � 𝜀 𝑁 𝑖, 𝑖 + 1 −  � 𝜀 𝐼𝑖𝑛−1
𝑖=2
𝑛−1
𝑖=1
 
 
εN … nearest neighbor extinction coefficient of neighboring nucleotides (i,i+1) 
εI … is the individual extinction coefficient for each nucleotide (i) 
 
Equation 1: Molar Extinction Coefficient. This formula was used to calculate the molar extinction coefficient at 260 nm of 
oligonucleotides.  
 
 
 
 
 
 
 
 
 
For longer sequences we used the following equation which is a mathematical approximation of 
Equation 1. 
𝜀260 = ∑(15,346.6 ∗ 𝑛𝐴;  11,751.8 ∗ 𝑛𝐺;  7,625.2 ∗ 𝑛𝐶 ;  9,929.7 ∗ 𝑛𝑈)  
Figure 28: Summary of extinction coefficients at 260nm. The values in the upper table state 
nearest-neighbor extinction coefficients (i, i+1); the lower table indicates extinction coefficients for 
each individual nucleotide (i); note that purine nucleotides absorb stronger than pyrimidine 
nucleotides, table was taken from www.operon.com. 
57 
The table below summarizes extinction coefficients of RNA and DNA oligos used in our 
experiments.  
Name 
Molar extinction coefficient 
[L•mol-1•cm-1] 
TS12 69,600 
BS12 98,600 
TS12-cold 146,400 
Sc 82 209,200 1 
Sc 160 208,200 
Sc 234 209,900 
Sc 312 206,400 
Sc 375 212,900 
Sc 440 274,000 
Sc 520 269,700 
Sc 588 200,800 
Sc 656 225,700 
Sc 682 369,500 
Sc 754 249,100 
Sc 833 179,000 
Sc 805 148,600 
Sc 866 191,900 
D123456 RNA 9,569,1002 / 1,0855,157.53 
D123456ex RNA 12,756,600 / XXXX fehlt noch 
  
                                                 
1 Sc oligos were calculated over the online calculator http://biophysics.idtdna.com/cgi-bin/uvCalculator.cgi. The calculator 
predicts extinction coefficients for single stranded DNAs and is based on Equation 1. 
2 Extinction coefficients for RNAs on the left were calculated with Equation 1 and the help of MatLab 7.12.0. 
3 Extinction coefficients for RNAs on the right were calculated with Equation 2 
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5. Kits, Devices and Enzyme Overview 
 
Identification Name Company Catalog # 
Ki
ts
 
Rosetta 2(DE3)pLysS Singles Competent Cell Kit Novagen 71401-3 
PureYield™ Plasmid Midiprep System Promega A2492 
MEGAshortscript™ T7 Kit Ambion AM1354 
RNA Purification MEGAClear™ Kit Ambion AM1908 
Malachite Green Phosphate Detection Kit R&D Systems DY996 
D
ev
ic
es
 
Microsep™ Centrifugal Devices (30K) Pall Life Sciences OD030C41 
PerfectPro Ni-NTA (Nickel-nitrilotriacetic acid) Agarose 
Nickel charged resin; max. pressure 2.8 psi (25 ml) 
5prime 
2400010 
Slide-A-Lyzer Dialysis Casette 10K (orange) Piercenet 66380 
Storage Phosphor Screen & Cassette 
Large Screen 35 x 43 cm, for Storm™, mounted GP4 
G&E Healthcare 
63-0034-82 
Image Eraser Amersham Biosciences - 
Molecular Dynamics Storm Phosphorimager 820 Molecular Dynamics - 
U-2000 Spectrophotometer Hitachi  
NanoDrop (ND-1000) Thermo Scientific - 
Gel Dryer Model GD-5040 SCIE-PLAS - 
µCLEAR plate, chimney, 96 well – black, clear bottom Greiner Bio-one 655087 
Infinite F500 microplate reader Tecan - 
Illustra™ Microspin™ G-25 Columns G&E Healthcare 27-5325-01 
En
zy
m
es
 
AMV Reverse Transcriptase  Promega M5108 
SUMO protease  Invitrogen 12588-018 
T4 Polynucleotide Kinase  NEB M0201S 
 
                                                 
4 GP: General purpose screen: for 125I, 32P, 33P, 35S, and 14C 
(http://www.gelifesciences.com/aptrix/upp01077.nsf/content/Products?OpenDocument&parentid=957136&moduleid=1637
35)  
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Identification Name Company Catalog # 
So
ftw
ar
e 
Image Quant™ Version 7.0 and ImageQuant TL 
SecurITy 8.0 Software Package  
G&E Healthcare 28-9380-94 
Molecular Dynamics Storm Scanner Control 
Version 5.01 
Molecular Dynamics - 
MATLAB 7.12.0; License # 165049 Mathworks® - 
PyMOL 1.1r1  PyMOL freeware 
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Methods 
 
1. Producing Recombinant Mss116p  
 
1.1. Transformation of pAS02 into Competent E. coli  
The transformation protocol is a modified version of the Novagen Manual User Protocol TB009 
Rev. F0104. We transformed 1 μl of pAS02 (c = 44.5 ng•μl-1) into 40 μl Rosetta 2(DE3)pLysS 
Singles Competent Cells (Novagen). For a negative control we used 10 μl of competent cells.  
• Cells were put on ice for 5 min, followed by a heat shock for 30 sec at 42 °C. 
• Then 250 μl of SOC medium (delivered with competent cell kit) was added and cells were 
incubated for 60 min at 37 °C with vigorous shaking.  
• The cells were centrifuged for 2 min, 6,000 rpm and supernatant was removed, except for 
~200 μl where the cells were resuspended carefully. 
• We plated 130 μl of cells on LB KAN plates, put plates at 37°C for overnight incubation 
and finally stored them at 4°C. 
For transformation the following reagents were used: 
LB KAN plates  
 10 g Bacto tryptone 
 5 g Yeast extract 
 5 g NaCl 
 15 g Agar 
Fill up to 1 L with ddH2O and autoclave the medium. After stirring and cooling media down 
to about 65°C, plates could be poured under a Lamina Flow Hood. Plates were stored at  4°C. 
Kanamycin (50 μl kanamycin [50 mg·ml-1] plus 50 μl ddH2O) was added directly on the plate 
before usage.  
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1.2. Expression of Mss116p in E. coli 
 
Overnight (o/n) Culture 
As the transformation plates were stored at 4°C a preparative culture is recommended before 
starting high level protein expression of Mss116p in E. coli Rosetta. Therefore 5 ml LB medium, 5 
μl kanamycin [50 mg·ml-1] and a single colony of the transformation plate was prepared. The 
inoculated culture was then incubated on a rotary shaker (200 rpm) at 37°C for o/n (about 12 – 16 
hours), allowing the cells to reach the stationary phase.   
 
Growth Cultures 
For high level Mss116p expression in E. coli Rosetta we set up three large growth cultures each 
consisting of 600 ml LB medium, 600 μl kanamycin [50 mg·ml-1] and 300 μl of o/n culture. The 
cells were incubated at 37°C with vigorous shaking to an optical density at 600 nm (OD600) of 0.4 
– 0.6. The OD600 was measured using a Hitachi U-2000 Spectrophotometer.  
  
IPTG-induced Protein Expression 
After growing bacterial cultures to the appropriate optical density (OD600 0.4 – 0.6) a 1 ml sample 
was withdrawn and centrifuged for 2 min at 8.500 rpm. The pellet was resuspended in 100 μl 
SDS PAGE sample buffer and stored at -20°C for subsequent polyacrylamide gel analysis. At this 
point protein expression was chemically induced with fresh 0.5mM IPTG. We incubated the 
bacterial culture overnight at 18°C with vigorous shaking. The next day a 1 ml sample was taken 
and again centrifuged for 2 min at 8.500 rpm. The pellet was resuspended in 100 μl SDS PAGE 
sample buffer and stored at -20°C for subsequent polyacrylamide gel analysis. 
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For expression of Mss116p in E. coli the following reagents were used: 
LB Medium 
 10 g Bacto tryptone 
 5 g Yeast extract 
 5 g NaCl 
Fill up to 1 L with ddH2O and autoclave it. 
 
1M IPTG  
 238 mg IPTG  
Fill up to 1 ml with ddH2O and store at -20°C. 
 
 
1.3. Recombinant Protein Purification 
 
Preparation of E. coli Lysate Under Native Conditions  
We harvested the cells by centrifugation at 6.500 rpm for 20 min at 4°C and the pellets were 
frozen for 30 min at -80°C. After thawing the pellets for 15 min on ice, the cells were resuspended 
in a total of 20 ml Lysis Buffer. 1 ml lysozyme (10 mg ml-1) was added and the sample was 
incubated on ice for 30 min. We further sonicated cells on ice with 6 x 10sec bursts and cooling 
samples on ice for 10 sec inbetween. The cells were harvested at 10.000 g for 30 min at 4 °C. 
We transferred the supernatant (SN) into a fresh 50ml falcon tube. The cell pellet (CP) was 
slightly resuspended in 5 ml lysis buffer. 20 μl samples from SN as well as from the CP were 
withdrawn and 80 μl SDS PAGE sample buffer was added. The samples were then analyzed on a 
10% SDS PAGE protein gel.  
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Batch Purification of 6 x HIS Tagged Mss116p from E. coli Under Native Conditions  
The PerfectPro Ni-NTA Agarose (5prime) was prepared by washing the resin two times with 
about 15 ml lysis buffer. We added 4 ml Ni-NTA agarose to cleared supernatant (1 ml to 4ml 
lysate) and mixed gently for 1 h on a rotary shaker at 4 °C.  The lysate-agarose mixture was then 
loaded onto a disposable polypropylene column (BioRad) with 20 ml capacity. The following 
purification steps were used to purify recombinant Mss116p: 
• Prior to purification 4ml of the flow through were collected for analysis 
• Afterwards, the resin was washed 4 x with 4 ml Wash Buffer I 
• Followed by 4 x washing with 4ml Wash Buffer II 
• Recombinant protein was then eluted 4 x with 4ml Elution Buffer 
From each purification fraction a 10 μl sample was taken and 10 μl SDS PAGE sample buffer 
added. The samples were analyzed on a 10% SDS PAGE protein gel.  
 
For recombinant protein purification the following reagents were used: 
0.5M Tris·HCl pH 6.8  
 15.1 g Tris  
Adjust pH with HCl. Afterwards fill up to 250 ml with ddH2O and autoclave it.  
 
3M KOH 
 8.4 g KOH    
Resuspend in 50 ml ddH2O. 
 
1M Imidazole 
 6.8 g Imidazole  
Resuspend in 100 ml ddH2O and store at 4°C. 
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3M KCl 
 111.4 g Potassium chloride 
Resuspend in 500 ml ddH2O and autoclave it.  
 
Lysis Buffer  
 10 ml 0.5M Tris·HCl pH 6.8  [f. c. 50mM] 
 10 ml 3M KCl   [f. c. 300mM] 
 1 ml  1M Imidazole  [f. c. 10mM] 
Adjust pH to 8.0 with KOH, fill up to 100 ml with ddH2O and store at 4°C. 
 
Wash Buffer I 
 10 ml 0.5M Tris·HCl pH 6.8  [f. c. 50mM] 
 10 ml 3M KCl   [f. c. 300mM] 
 5 ml 1M Imidazole  [f. c. 50mM] 
Adjust pH to 8.0 with KOH, fill up to 100 ml with ddH2O and store at 4°C. 
 
Wash buffer II 
 10 ml 0.5M Tris·HCl pH 6.8  [f. c. 50mM] 
 10 ml 3M KCl   [f. c. 300mM] 
 10 ml 1M Imidazole  [f. c. 100mM] 
Adjust pH to 8.0 with KOH, fill up to 100 ml with ddH2O and store at 4°C. 
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250mM Elution buffer  
 10 ml 0.5M Tris·HCl pH 6.8  [f. c. 50mM] 
 10 ml 3M KCl   [f. c. 300mM] 
 25 ml 1M Imidazole  [f. c. 250mM] 
Adjust pH to 8.0 with KOH, fill up to 100 ml with ddH2O and store at 4°C. 
 
 
 
1.4. Tag Cleavage, Concentration and Dialysis Against Storage Buffer 
 
Removal of the Tag Using the SUMO Protease  
The peak fractions from our batch purification were unified and protein concentration was 
measured by means of a Bradford Assay. To increase protein solubility after cleavage (85) we 
added5 
 4 µl  1M DTT    [f. c. 1mM] 
 8 µl  0.5M EDTA pH 8.0 (Ambion)  [f. c. 1mM] 
 400 µl 0.5M L-Arginine   [f. c. 50mM] 
 400 µl 0.5M L-Glutamine   [f. c. 50mM] 
 400 µl glycerol     [f. c. 10%] 
to the protein pool. For cleavage of the tag we prepared the following reaction: 
 
4 ml Mss116p pool [~0.5 mg·ml-1] 
100 μl + salt buffer 10 x (Invitrogen) 
100 μl - salt buffer 10 x  (Invitrogen) 
20 μl SUMO protease (Invitrogen) [20 units] 
                                                 
5 Addition of glycerol as well as the amino acids arginine and glutamine can increase solubility of cleaved protein from < 
1mg ml-1 up to 10 mg ml-1. The SUMO protease is a cysteinyl protease (Ulp1) and therefore EDTA presence has no 
inhibiting effect to the enzyme. 
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The cleavage reaction was incubated at 4°C overnight. With a spin-down for 10 min at 11.000 
rpm at 4°C we got rid of any precipitate. A 20 μl sample was withdrawn and mixed with 20 μl SDS 
PAGE sample buffer for analysis on a 10% SDS PAGE protein gel. Protein concentration was 
measured via a Bradford Assay.  
 
Concentration of Mss116p and Dialysis Against Storage Buffer 
 
Concentration  
To reach a higher protein concentration and to get rid of the cleaved SUMO tag (~13kDa) we 
used a Microsep Centrifugal Device 30 K (Pall Life Sciences). The device offers a cut off for 
molecules smaller than 30 kDa. We centrifuged for 2 hours and 7.000 rcf at 4°C to reach a 
concentration of ~ 10 μM. Protein concentration was determined by a Bradford Assay. A 20 μl 
sample was withdrawn and mixed with 20 μl SDS PAGE sample buffer for analysis on a 10% 
SDS PAGE protein gel.  
 
Dialysis 
We used Slide-A-Lyzer Dialysis Casettes (10K) for dialyzing protein against its storage buffer. 1 
liter protein storage buffer contains: 
 50 ml 1M  Tris·HCl pH 7.5  [f. c. 50mM] 
 1 ml 1M  DTT   [f. c. 1mM] 
 100 ml  3M  KCl   [f. c. 300mM] 
 100 ml glycerol   [f. c. 10%] 
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The concentrated protein samples were loaded into the cassette with a syringe as described in 
the manual of the manufacturer (see www.piercenet.com) and dialyzed at 4°C overnight with one 
time buffer change.  
 
On the next day, the protein sample was collected from the cassette with a syringe. We prepared 
20 μl aliquots and after shock freezing them in liquid nitrogen the samples were stored at -80°C.  
 
 
1M Tris·HCl pH 7.5   
 30.3 g Tris  
Adjust pH with HCl. Afterwards fill up to 250 ml with ddH2O and autoclave it. 
 
1M DTT 
 154 mg  DTT  
Add 1ml ddH2O, resuspend and store at -20°C.  
 
0.5M L-Arginine 
4.3 g L-Arginine (Sigma)  
Fill up to 50 ml with ddH2O and store at room temperature. 
 
0.5M L-Glutamine 
3.6 g L-Arginine (Sigma) 
Fill up to 50 ml with ddH2O and store at room temperature. 
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3M KCl 
 111.4 g Potassium chloride 
Resuspend in 500 ml ddH2O and autoclave it.  
 
 
1.5. Bradford Assay 
The Bradford Assay was used to determine Mss116p protein concentration. We prepared a 6 
point standard curve from a 100 µg·ml-1 BSA stock. A dilution series of the protein was prepared 
with 1, 2, 3 and 4 µl of protein in 20 µl ddH2O. The dilutions were added into the µCLEAR 96-well 
plate to 200 µl of Bradford Reagent (AppliChem). After incubating samples for ~20 minutes at 
room temperature the absorbance at 595nm (A595) was measured with the Infinite F500 
microplate reader (Tecan).  
µCLEAR Plate Assay - BSA Standard Dilution 
BSA standard 
BSA concentration 
[ng·µl-1] 
ddH2O 
[µl] 
BSA of stock 
[µl] 
1 0 20 - 
2 0.9 18 2 
3 1.81 16 4 
4 2.72 14 6 
5 4.54 10 10 
6 6.18 5 15 
7 9.09 - 20 
 
The microplate reader out-put was processed in Excel and protein concentration was calculated 
by comparing OD595nm of the protein sample to the BSA straight calibration line.  
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1.6. SDS-PAGE 10% Protein Gels 
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) is a technique to 
separate proteins of different molecular weight. SDS is a detergent and reduces disulfide bonds 
which break protein tertiary structures. Heating up samples to 97°C further denatures proteins 
and allows coating by SDS which results in an egg-shaped conformation and an increased 
negative charge proportional to protein size. Smaller proteins therefore migrate much faster 
through the acrylamide network than larger ones. Proteins of different sizes can then be identified 
over Coomassie staining. Gels for protein electrophoresis were prepared as described in the 
following chapters.  
 
1.6.1.  Preparation of Gels 
The amount of gel prepared was enough for two gels (0.75mm). First the separating gel was 
prepared and poured into a Dual Gel Caster (SE245, Hoefer). The gel was covered on top with a 
thin layer of Ethanol (to smoothen the surface) and allowed to polymerize (by adding 100 µl 10% 
APS and 10 µl TEMED). Afterwards the stacking gel was poured and a comb inserted. When 
stacking gel was polymerized the comb was removed and gels were installed on a Mini-vertical 
gel electrophoresis unit (SE250, Hoefer) in 1 x GTS buffer. Protein samples were boiled at 97°C 
for 5 minutes before loading into slots. We run gels with 140 Volts for about 1 hour and 20 
minutes. For all samples the below mentioned SDS-PAGE sample buffer was used.  
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Separating gel 
Reagent 10% SDS-PAGE 
Water  4.87 ml  
1.5M T Tris·HCl pH 8.8  2.5 ml  
10% SDS  100 µl 
40% Acrylamide/bisacrylamide  2.48 ml 
 
 
Stacking Gel 
Reagent 10% SDS-PAGE 
Water  3.83 ml  
1.5M T Tris·HCl pH 6.8  625 µl  
10% SDS  50 µl 
40% Acrylamide/bisacrylamide  487.5 µl 
 
The reagents listed below were used for preparing the gels.  
1.5M Tris·HCl pH 8.8   
 45.4 g Tris  
Adjust pH with HCl. Afterwards fill up to 250 ml with ddH2O and autoclave it. 
 
0.5M Tris·HCl pH 6.8  
 15.1 g Tris  
Adjust pH with HCl. Afterwards fill up to 250 ml with ddH2O and autoclave it. 
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10% SDS 
  5 g SDS  
Dissolve carefully in 50 ml ddH2O. 
 
10% APS 
  1.5 g APS  
Suspend in 15 ml ddH2O and store at 4°C protected from light. 
 
10 x GTS 
 60 g TRIS base  [f. c. 250mM] 
 288 g glycine [f. c. 1.92M] 
 20 g  SDS [f. c.  1%] 
Add ddH2O up to 2 L and filter but do not autoclave. 
 
SDS-PAGE sample buffer  
 10 ml 0.5M Tris·HCl pH 6.8  [f. c. 0.1M] 
 10 ml glycerol  [f. c. 20%] 
 10 ml 10% SDS  [f. c. 2%] 
 10 mg Bromphenol blue  [f. c. 0.02%] 
Fill up to 50ml with ddH2O and add ß-Mercaptoethanol always fresh before use [f. c. 5%]. 
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1.6.2.  Coomassie Staining of Protein Gels 
After gel run, the Mini-vertical gel electrophoresis unit was disassembled, the stacking gel was cut 
off and separating gel was stained with about 10 ml staining solution with gentle shaking on a 
shaker platform for 10 minutes. Protein bands were visualized by subsequent de-staining. 
 
Staining Solution 
 125 ml Methanol     [f. c. 50%] 
 25 ml Acetic acid    [f. c. 10%] 
 625 mg Coomassie Brilliant Blue R250  [f. c. 0.25%] 
Fill up to 250ml with ddH2O. 
 
De-staining Solution 
 50 ml Methanol  [f. c. 5%] 
 75 ml Acetic acid [f. c. 7.5%] 
Fill up to 1 L with ddH2O. 
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2. Preparing In Vitro Transcribed RNA 
   
2.1. Plasmid Purification and Preparation 
In order to produce plasmid DNA the following transformation was set up: 
 
Transformation of pEL85 and pJD20 
For plasmid preparation we transformed ~ 50 ng·µl-1 of plasmid DNA into DH5α competent cells. 
A typical transformation protocol was performed as follows: 
• We used 50 µl DH5α competent cells and added 1 µl of plasmid DNA (c ~ 50 ng·µl-1). 
• For the negative control we used 50 µl DH5α competent cells.  
• The tubes were carefully flipped and incubated on ice for 30 min. 
• We performed a 30 sec heat shock at 42°C. 
• After placing cells immediately on ice for 5 min we added 950 µl LB medium and 
incubated the cells at 37°C for 1 hour with vigorous shaking. 
• After a short spin down for 2 min at 5.000 rpm, the cells were resuspended in 100 µl 
medium and plated on selective LB plates.  
• The plates were incubated at 37°C overnight and afterwards stored at 4°C until usage.  
 
Preparative Cultures 
We prepared 5 ml LB and added one colony of the transformation plate. 5 µl of a 1000x stock of 
antibiotics (1:1000) were added and culture was incubated at 37° C with vigorous shaking for 
about 5 hours. This culture was then added to 250 ml LB containing 250 µl 1000x antibiotic and 
afterwards incubated for 17-21 hours at 37°C shaking vigorously.  
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Plasmid Midiprep 
We used a PureYield™ Plasmid Midiprep System (Promega) to isolate plasmid DNA of 
preparative culture. DNA purification was performed as described in the PureYield™ Plasmid 
Midiprep System Technical Manual (Quick Protocol). DNA concentration was measured using the 
NanoDrop device.  
 
Linearizing the Plasmid 
To linearize the plasmid we performed a restriction digest with a single cutting enzyme. We cut 
the pEL85 construct with BamHI (NEB; 20,000 units·ml-1) and pJD20 with HindIII (NEB; 20,000 
units•ml-1). A typical restriction digest was prepared as follows:  
 100  µg plasmid DNA 
 50  µl  10x NEBuffer 2  
 5  µl  100x BSA (NEB) 
 3  µl  restriction enzyme (20 U/µl) 
Fill up to 500 µl with ddH2O and incubate the digest on 37°C overnight. 
 
Purification of the Linearized Vector 
After the overnight digest the linearized plasmid was purified via Phenol Chloroform 
Isoamylalcohol (PCI) extraction. For this we added 
• 500 µl PCI (250 µl Phenol/250 µl CI) vortexed well and centrifuged for 5 min at 13,000 
rpm. 
• We transferred the upper phase in a new 1.5ml Eppendorf tube and added 500 µl CI 
followed by vortexing and centrifuging for 3 min at 13,000 rpm.  
• The upper phase was again carefully transferred into a new 1.5 ml Eppendorf tube 
followed by precipitation with 2.5 x EtOH/0.3M NaOAc at -20°C for 1 hour. 
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• After precipitation we centrifuged at full speed at 4°C for 30 min and washed the pellet 
with 70% Ethanol. 
• After letting the pellet dry we resuspended it in 50 µl ddH2O and measured DNA 
concentration using a NanoDrop.  
 
LB Medium and selective plates 
 10 g Bacto tryptone 
 5 g Yeast extract 
 5 g NaCl 
 15 g Agar (for LB plates) 
For LB medium we filled up to 1 L with ddH2O and autoclaved.   
For LB plates we stirred medium and let it cool down to a temperature of about 65°C. Then the 
antibiotic was added and plates were poured under a Lamina Flow Hood. Plates were stored at 
4°C.  
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2.2. In Vitro T7 Transcription 
For pEL85 and pJD20 a typical 1 ml transcription reaction was prepared as described below: 
 5  µl  linearized plasmid DNA [c ~ 25 µg] 
 100  µl  10 x TRA buffer 
 10  µl  1 M DTT 
 20  µl ATP (100mM) 
 20  µl  UTP (100mM) 
 20  µl  GTP (100mM) 
 20  µl  CTP (100mM) 
 5  µl  rRNasin (Promega; 40 u·µl-1) 
 40  µl  T7 RNA polymerase (lab made) 
 760  µl  ddH2O 
The reaction was assembled on ice and incubated for 3-4 hours at 37°C. Finally the RNA was 
precipitated by adding 50 µl 0.5M EDTA pH 8.0 (Ambion) and 3 ml 2x vol. EtOH/0.3M NaOAc  
and freezing it at -20°C for 1 hour. Afterwards we centrifuged at 4°C for 30 min at maximum 
speed, discarded the supernatant, air-dried the pellet and resuspended the RNA in 30 µl ddH2O 
and 100 µl 7 M urea loading dye. The RNA was then purified using a 5% denaturing 
polyacrylamide gel.  
 
1M Spermidine 
 254.6 mg Spermidine (AppliChem)   
Fill up to 1ml with ddH2O and store at -20°C.  
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10 x Transcription buffer (TRA) 
 400 µl 1M Tris·HCl pH 7.5 (AppliChem)  [f. c. 400mM] 
 260  µl 1M MgCl2 (Ambion)   [f. c. 260mM] 
 30 µl 1M Spermidine     [f. c. 30mM] 
Fill up to 1ml with ddH2O and store at -20°C 
 
100mM Nucleotide (AppliChem) Preparation 
We prepared nucleotides the following way: we made 1 ml of an approximately 200mM solution. 
For this we took dry NTP, in the below listed amount, added 20 µl 1M Tris•HCl pH 7.5 
(AppliChem) and approximately 50-90 µl freshly prepared 5M NaOH to adjust the pH to 7. We 
took the below stated amounts of NTP, NaOH and water for the stock solutions.  
 
  GTP CTP UTP ATP 
 
 NTP 128 134 140 130 mg 
 5 M NaOH 48 84 48 88 µl  
 ddH2O 932 896 932 892 µl   
 
The pH was checked using pH-indicator strips (Merck) and the concentration measured using a 
NanoDrop device. The NTP stock solutions were stored at -80°C. For 100mM NTP solutions we 
diluted the stock to a final concentration of 100mM and stored them at -20°C.   
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5M NaOH 
 10 g Sodium Hydroxide Pellets 
Fill up with ddH2O to 50 ml.  
 
1M Dithiothreitol (DTT) 
 154 mg Dithiothreitol  
Add 1 ml ddH2O and store at -20°C.  
 
10 x TBE 
 540 g Tris base  [f. c. 890mM] 
 275 g Boric acid  [f. c. 890mM] 
 29.2 g EDTA   [f. c. 20mM] 
Fill up to 5 L with ddH2O, stir and autoclave it.  
 
7M Urea Loading Dye 
 6.3 g UREA [f. c. 7M] 
 3.75 ml D(+)-Sucrose [f. c. 25%] 
 37 mg Bromphenol Blue [f. c. 0.25%] 
 37 mg Xylene Cyanol [f. c. 0.25%] 
                1.5  ml 10x TBE 
Fill up to 15 ml with H2O and store at room temperature.  
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2.3. RNA Purification via a 5% Denaturing Polyacrylamide Gel 
Size-exclusion chromatography was used to purify the reverse transcribed RNA. We prepared a 5 
% Polyacrylamide (PAA) gel. For this we took 60 ml of 5% AA, added 500 µl APS and 50 µl 
TEMED. The gel was mixed briefly, poured and allowed to polymerize. We pre-heated the gel by 
running it for 20 min with 25 W. With a syringe and 1 x TBE buffer we flushed away diffused urea 
from the wells. The RNA samples were loaded and the gel was run by 25 W for ~ 2 hours, until 
the Xylene Cyanol dye reached the bottom of the gel. After removing gel from both of the glass 
plates and covering it with saran wrap we cut bands under UV light and transferred the gel pieces 
into 2 ml tubes. We added 1 ml elution buffer and incubated the samples at -20°C overnight. The 
next day we let the samples sit for 10 min at room temperature and incubated them afterwards on 
a rotating wheel at 4°C for 3-4 hours. Samples were centrifuged shortly and the supernatant was 
transferred to a 5 ml syringe (Omnifix) connected to a sterile syringe filter (0.2 µm). The filter was 
rinsed by adding another 200 µl of elution buffer to the syringe. We split the filtrate in two 2 ml 
tubes and added 4 µl glycogen [10 mg·ml-1] and 600 µl 100% Ethanol. We precipitated at -20°C 
overnight. After centrifugation for 30 – 60 minutes at 4°C full speed we air-dried the pellet and 
resuspended the RNA in 20 µl ME buffer. The RNA concentration was measured over NanoDrop 
device, RNA quantity was calculated as described and the quality of RNA was checked on a 1% 
agarose gel as described below. 
 
5% Acrylamide (AA) 
 62.5 ml 40 % Acrylamide-Solution Mix 19:1 
 210 g Urea 
 50 ml 10 x TBE 
Fill up to 500 ml with ddH2O, stir, filter and store at 4°C.  
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10% APS 
 1 g APS [f. c. 10%] 
Add 10 ml ddH2O and store at 4°C protected from light.  
 
1M MOPS buffer 
 52.3 g MOPS  
Add ~100 ml ddH2O and adjust pH with NaOH. Then fill up to 250 ml with ddH2O, filter over 
Nalgene filter units and store buffer at 4°C protected from light.   
 
Elution buffer  
 500 µl 1M MOPS pH 7.0 [f. c. 10mM] 
 4.2 ml 3M NaOAc pH 5.0 (Ambion) [f. c. 250mM] 
 200 µl 0.5M EDTA pH 8.0 (Ambion) [f. c. 2mM] 
Complete with ddH2O to 50 ml.  
 
ME buffer 
 500 µl 1M MOPS pH 6.0 [f. c. 10mM] 
 100 µl 0.5M EDTA pH 8.0 (Ambion) [f. c. 1mM] 
Complete with ddH2O to 50 ml. 
 
Glycogen [10 µg·µl-1] 
 10 mg glycogen  
Add 1ml ddH2O, filter through a syringe connected to a filter and store at -20°C.   
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10 x TBE 
 540 g Tris base  [f. c. 890mM] 
 275 g Boric acid  [f. c. 890mM] 
 29.2 g EDTA  [f. c. 20mM] 
Fill up to 5 L with ddH2O, stir and autoclave it.  
 
 
2.4. Determination of RNA Quantity and Quality 
RNA Quantity 
The final RNA concentration [µM] was calculated using a modified Beer-Lambert equation: 
 
[µ𝑀] = (𝐴260 ∗ 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 ∗ 106)
𝜀
 
 
ε ... wavelength dependent extinction coefficient [L·mol-1·cm-1] A260 … absorbance at 260 nm  
 
The wavelength dependent extinction coefficients are listed in section Oligonucleotide 
Specification and Quantification. 
 
Visualizing Presence of RNA 
To visualize presence of RNA, a small sample (0.2 µg) was loaded on a 1% agarose gel. RNA 
concentration was measured using a NanoDrop device and 0.2 µg of RNA was prepared in 4 µl 
ddH2O together with 6 µl 7 M UREA loading dye. The samples were loaded on the gel was run for 
~ 40 min at 120 V in 1 X TBE. Presence of RNA was checked with EtBr staining. If required RNA 
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quality can simply be determined over a denaturing polyacrylamide gel. RNA of good quality 
shows a sharp band without smear.  
 
1% agarose gel 
For 250 ml 1 % agarose we used 2.5 g agarose and 250 ml 1 x TBE. The agarose was boiled 2 -
3 times in the microwave until all agarose particles were melted. We stored it at 65°C until its 
usage. For one small agarose gel we used 50 ml agarose containing 1 µl ethidium bromide 1 % 
solution [10 mg·µl-1]. 
 
7M Urea Loading Dye 
 6.3 g UREA [f. c. 7M] 
 3.75 ml D(+)-Sucrose [f. c. 25%] 
 37 mg Bromphenol Blue [f. c. 0.25%] 
 37 mg Xylene Cyanol [f. c. 0.25%] 
                1.5  ml 10 x TBE 
Fill up to 15 ml with ddH2O and store at room temperature.  
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3. Oligonucleotide and RNA Labeling 
  
3.1. Primer 5’ End Labeling 
Using the T4 Polynucleotide Kinase (PNK) and γ-32P ATP, radiolabeled γ-phosphate group is 
transferred to the 5’OH group of oligos or RNA. For a reaction we used equimolar amounts of 
oligo and γ-P32-ATP [6000 Ci·mmol-1]: 
 2  µl  10x PNK buffer  
 1  µl  10µM oligo  
 6  µl  γ-32P ATP [10 µCi·µl-1] 
   added ddH2O up to 19 µl  
 1  µl  T4-PNK [10 u·µl-1] (NEB) 
 
• We incubated the samples at 37°C for 40 minutes. 
• 1 µl 0.5 M EDTA pH 8.0 was added and samples were incubated at 95°C for 1 min and 
then put immediately on ice for 2 min. 
• The primers were precipitated with 1 µl glycogen [10 µg·µl-1] and 2.5x vol. Ethanol/0.3M 
NaOAc pH 5.0 and frozen at -20°C for 1 hour. 
• After centrifugation at 4°C full speed for 30 min we discarded the supernatant, washed 
the pellet with 70 % Ethanol and dried it carefully for 5 min at room temperature. 
• Finally the pellet was resuspended in 40 µl ddH2O and stored at -20°C. 
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3.2. 5’ End Labeling of TS12  
For 5’ labeling of the top strand TS12 we used: 
 20 pmol TS12 RNA 
 5 μl T4 PNK buffer (NEB) 
12 μl γ-32P ATP [10 µCi·µl-1] 
 2 µl  T4-Polynucleotide Kinase [10 u·µl-1] (NEB) 
 We increased the volume to 20 µl with ddH2O. 
 
• The reaction mixture was incubated for 40 min at 37°C. 
• Afterwards we added 1 µl 0.5 M EDTA pH 8.0 (Ambion), placed the reaction on 95°C for 
1 min and precipitated with 1 µl glycogen [10 µg·µl-1] and 150 µl EtOH/0.3M NaOAc 
(Ambion) pH 5.0 for 1 hour at -20°C. 
• After a 30 min centrifugation step (4°C, maximum speed) the pellet was resuspend in 10 
µl ddH2O. We added 30 pmol of cold TS12 RNA as there is a 5x molar excess of top 
strand over the bottom strand BS12 required for efficient duplex formation (168).  
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3.3. Body Labeling of Ai5γ Pre-RNA for the Cis-splicing Assay  
We used α-P32 UTP and T7 RNA polymerase were used to randomly incorporate the labeled-
nucleotides (as α-P32-UMP) into the transcript, thereby producing body-labeled ai5γ pre-RNA.  
 ~ 2.5 μg  linearized pJD20 plasmid DNA 
 5 μl 10 x TRA buffer 
 0.5 μl 1M DTT 
 3 μl ATP, GTP, CTP [100mM]  
 1.5 μl UTP [100mM]  
 5 μl α-P32 UTP [10 µCi·µl-1] 
 1 μl rRNasin [40 U·µl-1] (Promega) 
 4 μl T7 RNA Polymerase (lab made) 
 
We filled up to 50 μl with ddH2O and incubated the reaction at 37 °C for 1 ½ hours. Afterwards 
DNA was digested with 2 μl DNAse I [1 U·µl-1] (Fermentas) for 15 min at 37 °C. Ai5γ pre-RNA was 
then purified over the MEGAclear™ Kit.   
 
Purification of the Ai5γ pre-RNA Using the MEGAclear™ Kit 
ai5γ pre-RNA was purified as described in the user manual 
(www.ambion.com/techlib/prot/bp_1908.pdf). 100% Ethanol was required as it was not provided 
with the kit. The RNA was resuspended finally in 100 μl ddH2O and stored at -20°C.   
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4. Reverse Transcription 
To examine protein dependent structural changes within RNA we used metal-induced cleavage 
assays in combination with reverse transcription. On the basis of the RNA fragments of different 
length produced in the metal-induced cleavage assay, a cDNA pool was created during reverse 
trancription. The resulting cDNA pattern reflected the changes in the RNA molecule structure. In 
our experiments we used 0.5 pmol of RNA, 32P-labeled primers and AMV reverse transcriptase.  
 
4.1. Primer Annealing Reaction 
The annealing reactions contained:  
 2.5 µl purified RNA (0.5 pmol modified RNA and RNA for A/C lane, 
0.75 pmol for samples that containg Mss116p during the 
metal-induced cleavage assay6) 
 1 µl 32P-labeled primer [0.25µM] 
 1 µl 4.5 x Hybridization buffer 
The samples were incubated at 95°C for 1 minute. Afterwards we adjusted the heating block to 
55°C and let it cool slowly.  
 
4.2. Extension of Primer 
For primer extension we used 
 2 µl 5 x AMV Extension buffer 
 0.7 µl 10mM dNTP mix 
 1.4 µl ddH2O 
 0.3 µl AMV Reverse Transcriptase [10 u·µl-1] 
                                                 
6 Purified Mss116p protein is not completely without impurities (RNAses). To balance the RNA loss a larger amount of 
RNA (0.75 instead of 0.5 pmol) was used for reverse transcription.  
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For A and C lane we added 1 µl of 1mM ddNTP in addition to the extension mix (Amersham 
Biosciences).  
• The samples were incubated at 55°C for 20 min. 
• Then 1.5 µl 1 M NaOH was added in order to degrade the RNA and samples were 
incubated for further 20 min at 55°C. 
• We added 1.5 µl 1 M HCl to neutralize the pH and 
• precipitated with 
 1 µl glycogen [10 mg·ml-1] 
 1 µl 0.5M EDTA pH 8.0 (Ambion) 
 45 µl Ethanol/0.3M NaOAc pH5.0  
• The samples were frozen at -20°C 1 hour to overnight (alternatively at -80°C)  
• Centrifuge the samples at 4°C at full speed for 30 – 60 min. 
• The supernatant was discarded; the pellet washed with 70% Ethanol and the dried pellet 
was resuspended in 10 µl 7 M Urea Loading buffer. 
• We loaded samples on an 8% denaturing PAGE for analysis.  
 
1M NaOH 
 6 g NaOH 
Dissolve pellets in 15 ml  ddH2O. Dilute 10M NaOH solution 1:10 with ddH2O.  
 
1M HCl 
 4.6  ml 33% HCl 
 55.4 ml ddH2O 
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dNTP mix  
 10  µl 100mM dATP [f. c. 10mM] 
 10 µl 100mM dGTP [f. c. 10mM] 
 10 µl 100mM dCTP [f. c. 10mM] 
 10 µl 100mM dTTP [f. c. 10mM] 
 60 µl ddH2O 
We stored dNTPs at -20°C. We used a 100mM dNTP set (as Li-salt) from Roche.  
 
10 x Extension buffer 
 650 µl 2M TRIS·HCl pH 8.0 [f. c. 1.3M]  
 100 µl 1M MgCl2 (Ambion) [f. c. 100mM] 
 100 µl 1M DTT [f. c. 100mM] 
Fill up with ddH2O to 1ml, aliquot and store at -20°C. 
 
4.5 x Hybridization buffer 
 225 µl 1M K-Hepes pH 7.0 (AppliChem) [f. c. 225mM]  
 225 µl 2M KCl (Ambion)  [f. c. 450mM] 
fill up with ddH2O to 1ml, aliquot and store at -20°C. 
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7M Urea Loading Dye 
 6.3 g UREA [f. c. 7M] 
 3.75 ml D(+)-Sucrose [f. c. 25%] 
 37 mg Bromphenol Blue [f. c. 0.25%] 
 37 mg Xylene Cyanol [f. c. 0.25%] 
                1.5  ml 10 x TBE [f. c. 1x] 
Fill up to 15 ml with ddH2O and store at -20°C.  
 
4.3. 8% Denaturing Polyacrylamide Gel-Electrophoresis (PAGE) 
We used an 8 % Polyacrylamide (PAA) gel to separate the cDNA pool resulting from the reverse 
transcription. For this we used 60 ml of 8% AA, 500 µl 10% APS and 50 µl TEMED were mixed 
together and the gel was poured and allowed to polymerize (for at least 1 hour). We pre-heated 
the gel by running it for 30 min with 40 W. With a syringe and 1 x TBE buffer we flushed away 
diffused urea from the wells. The RNA samples were loaded and the gel was run by 40 W for ~ 
1.5 hours, until the Bromphenol Blue dye reached the bottom of the gel. After removing the upper 
glass plate the gel was transferred on Whatman 3M® paper. The second glass plate was carefully 
withdrawn and the other side of the gel was covered with saran wrap. After drying the gel ~ 1.5 
hours in a Gel Dryer (80°C, vaccum) it was exposed to a Storage Phosphor Screen (GE 
Healthcare) and stored overnight in a cassette. The next day the screen was scanned with a 
Phosphor Imager (GE Healthcare) and the result was analyzed with Image Quant TL software 
(GE Healthcare).  
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8% Acrylamide (AA) 
 100 ml 40 % Acrylamide-Solution Mix 19:1 
 210 g Urea 
 50 ml 10 x TBE 
Fill up to 500 ml with ddH2O, stir, filter and store at 4°C.  
 
10% APS 
 1 g APS [f. c. 10% (w/v)] 
Add 10 ml ddH2O and store at 4°C protected from light.  
 
10 x TBE 
 540 g Tris base  [f. c. 890mM] 
 275 g Boric acid  [f. c. 890mM] 
 29.2 g EDTA  [f. c. 20mM] 
Fill up to 5 L with ddH2O, stir and autoclave.  
 
5. Protein Activity Assays 
Before we started structural probing of ai5γ in the presence and absence of Mss116p we wanted 
to verify that our purified recombinant Mss116p is able to perform its enzymatic functions: 
promoting self-splicing of the ai5γ intron, unwinding of RNA duplex and ATP hydrolysis. 
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5.1. In vitro Splicing Assays 
By performing cis-splicing assays with the ai5γ pre-RNA (full length intron flanked by part of the 
exons) in the absence and presence of Mss116p, we tested the activity of the recombinant 
Mss116p/∆MLS protein. Notably, it has previously been reported that Mss116p can promote 
group II intron splicing at near-physiological ionic and temperature conditions. Below we describe 
the experimental set up. Notably, a positive control for which  ai5γ pre-RNA was folded and 
spliced under high-salt conditions and elevated temperature (100mM MgCl2, 500mM NH4Cl, 
42°C). As negative control the ai5γ pre-RNA was folded at near-physiological conditions in the 
absence of Mss116p (8mM MgCl2, 100mM NH4Cl, 30°C), which does not promote self-splicing. In 
brief, we incubated the full-length body labeled ai5γ precursor RNA in 40mM MOPS, pH 7.5 at 
95°C for 1 min and subsequently at 30°C for 3 min. For reactions in the presence of Mss116p, the 
reaction mixtures contained 600nM Mss116p, 8mM MgCl2, 1mM ATP (in a mix with 1mM MgCl2). 
The reaction was incubated at 30°C, aliquots were withdrawn at selected time points and the 
reaction was stopped with Proteinase K and 15 µl stop buffer. Half of the sample was analyzed 
on a 5% denaturing polyacrylamide gel (see section 2.3). The autoradiography was performed as 
described in section 0.  
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Mss116p and ai5γ pre-RNA (exD123456) in vitro splicing assay 
Action Reagent + control - control + Mss116p 
  ai5γ pre-RNA 32P labeled 1 μl 1 μl 1 μl 
ADD 1M MOPS pH 7.0  [f. c. 40mM] 1 μl 1 μl 1 μl 
ADD ddH2O  12.25 μl 19.97 μl 16.05 μl 
denature RNA for 1 min at 95 °C 
3 min at 30 °C 
spin down 
ADD 
1M MgCl2 (Ambion) 
+ control [f. c. 100mM] 
0.1M MgCl2 (Ambion) 
 - control and Mss116p [f. c. 8mM] 
2.5 μl 2 μl 2 μl 
ADD 600 nM Mss116p [6.66μM]  - - 2.25 μl 
ADD 2M NH4Cl [f.c. 500mM] 6.25 μl - - 
ADD 
3M KCl (Ambion) 
 - control [f. c. 100mM] 
- 0.83 μl - 
ADD 
10mM ATP/Mg2+ mix [f. c. 1mM] 
(AppliChem) 
includes 10 mM MgCl2 (Ambion) 
- - 2.5 μl 
ADD rRNasin [40 U/μl] (Promega) 2 μl 2 μl 2 μl 
total  25 μl 25 μl 25 μl 
mix gently  
(+) control: incubate at 42 °C, (-) control and Mss116p sample: incubate at 30°C 
withdraw aliquots (3 µl) after 0, 10, 20, 30, 60 and 120 min 
aliquot treatment 
To each 3 μl aliquot add 1 μl of Proteinkinase K (AppliChem) in case of Mss116p-containing samples 
and 
Incubate for 1 min at room temperature and then add 15 μl Stop buffer (to all aliquots)  
store at -20 °C 
analyze half of sample on a 5 % PAA gel  
(note: the second dye (xylene cyanol) should reach the bottom of the gel!) 
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2M NH4Cl 
 5.3 g Ammoniumchlorid   
Add 50 ml ddH2O and filter through syringe with an acrodisc filter (0.2µm) attached.  
 
10 x TBE 
 540 g Tris base  [f. c. 890mM] 
 275 g Boric acid  [f. c. 890mM] 
 29.2 g EDTA [f. c. 20mM] 
Fill up to 5 L with ddH2O, stir and autoclave it.  
 
Stop buffer 
The stop buffer used in the above described in vitro splicing assay is a combination of the 
following three solutions. 
Solution 1 
 500 µl sucrose (AppliChem)  [f. c. 50%] 
 100 µl 10xTBE   [f. c. 1xTBE] 
 500 µl ddH2O   
Solution 2 
 800 µl formamide   [f. c. 80%] 
 200 µl solution1  [f. c. 20%] 
Solution 3 
 100 µl 0.5M EDTA pH 8.0 (Ambion)  [f. c. 50mM] 
 900 µl solution 2    [f. c. 100%] 
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1M MOPS pH 7.0 
 52.3 g MOPS  
Add ~200 ml ddH2O and adjust pH to 7.0 with 10M KOH. Then fill up to 250 ml with ddH2O, filter 
over Nalgene filter units and store buffer at 4°C protected from light. Take the dilution effect into 
account!   
 
 
5.2. Unwinding Assays 
 
Duplex Formation 
For BS/TS12 duplex formation we used a 5x molar excess of labeled TS12 strand over the 
complementary BS12 strand (168). We prepared a reaction mixture containing 50pmol 32P 
labeled TS12 strand (is a mixture of 30pmol cold TS12 and 20pmol labeled TS12) and 10pmol of 
BS12 in 10mM MOPS pH 6.5 and 1mM EDTA pH 8.0 (Ambion). The reaction was heated up to 
95°C for 2 min and cooled down to room temperature slowly (takes ~ 90 minutes). The duplexes 
were separated over Illustra™ Microspin™ G-25 Columns (for working protocol see protocol of 
manufacturer) and duplex was stored at -20°C. 
 
1M MOPS pH 6.5 
 52.3 g MOPS  
Add ~200 ml ddH2O and adjust pH to 6.5 with 10M KOH. Then fill up to 250 ml with ddH2O, filter 
over Nalgene filter units and store buffer at 4°C protected from light.   
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Unwinding Assay of 12bp Blunt End Duplex 
For the unwinding assays we used 5nM labeled TS/BS12 RNA duplex and 400nM Mss116p in 1 
x Helicase Reaction Buffer (HRB). The mixture was incubated for 10min at 30°C and reaction 
was initiated with the addition of 20mM ATP/MgCl2-mix [f.c.]. As a negative control we prepared 
one reaction without MgCl2 and one without Mss116p. To create a single stranded size marker an 
additional aliquot was withdrawn, heated up to 95°C for 2 min and placed on ice. Samples were 
taken at time point 0, 30 and 60 minutes and the reaction was stopped with Helicase Reaction 
Stop Buffer (HRSB). We loaded the samples on a 15% non-denaturing polyacrylamide gel (68). 
 
1M Tris·HCl pH 8.0 
 30.2 g Tris  
Dissolve salt in 200 ml ddH2O. Adjust pH to 8.0 with HCl. Afterwards fill up to 250 ml with ddH2O 
and autoclave it.  
 
10% SDS 
  5 g SDS  
Dissolve carefully in 50 ml ddH2O. 
 
0.5% IGEPAL 
 75 µl IGEPAL® CA-630 (Sigma) 
Fill up to 15 ml with ddH2O. 
 
1M DTT 
 154 mg Dithiothreitol  
Add 1 ml ddH2O and store at -20°C.  
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2 x Helicase Reaction SDS Stop Buffer (HRSB) 
 1 ml 0.5M EDTA pH 8.0   [f. c. 50mM] 
 1 ml 10% SDS   [f. c. 1%] 
 10 mg Bromphenol blue   [f. c. 0.1%] 
 10 mg Xylene Cyanol   [f. c. 0.1%] 
 2 ml glycerol   [f. c. 20%] 
Fill up to 10 ml with ddH2O and store at room temperature.  
 
10 x Helicase Reaction Buffer (HRB) 
 4 ml 1M Tris·HCl pH 8.0  [f. c. 400mM] 
 50 µl 1M MgCl2 (Ambion)  [f. c. 5mM] 
 2 ml 0.5% IGEPAL   [f. c. 0.1%] 
 200 µl 1M DTT   [f. c. 20mM] 
Fill up to 10 ml with ddH2O, aliquot in 1 ml tubes and store at -20°C.  
 
15% Non-Denaturing PAGE 
The 15 % non-denaturing PAGE was used to visualize unwinding of the 12bp blunt end duplex 
TS/BS12 in the presence of Mss116p. For this we used 60 ml of 15% AA, 500 µl 10% APS and 
50 µl TEMED were mixed together and the gel was poured and allowed to polymerize. We pre-
heated the gel by running it for 20 min with 40 W. Using a syringe filled with 1 x TBE buffer we 
flushed away diffused urea from the wells. The samples were loaded and the gel was run by 30 
W for ~ 1 hour in 1 x TBE buffer. After removing the upper glass plate the gel was covered with 
Saran wrap first. This is important because otherwise the gel can be easily destroyed due to the 
dryness of a 15% PAGE gel. The second glass plate was carefully withdrawn and the other side 
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of the gel was covered with Whatman 3M® paper. After drying the gel ~ 1 hour in a Gel Dryer 
(80°C, vaccum) it was exposed to a Storage Phosphor Screen (GE Healthcare) and stored 
overnight in a cassette. The next day the screen was scanned with a Phosphor Imager (GE 
Healthcare) and the result was analyzed with Image Quant TL software (GE Healthcare).  
10 x TBE 
 540 g Tris base  [f. c. 890mM] 
 275 g Boric acid  [f. c. 890mM] 
 29.2 g EDTA [f. c. 20mM] 
Fill up to 5 L with ddH2O, stir and autoclave it.  
 
15% Acrylamide (AA) 
 93 ml 40% Acrylamide/bisacrylamide [f. c. 15%] 
 25 ml 10 x TBE    [f. c. 1x TBE] 
Fill up to 250 ml with ddH2O, filter and store at 4°C.  
 
5.3. Malachite Green ATPase Assays 
The Malachite Green Phosphate Detection Kit (R&D Systems) is a method which determines the 
concentration of free inorganic phosphate (Pi). It is based on the complexation of malachite 
green, ammonium molybdate and free inorganic phosphate under acidic conditions. First the free 
orthophosphate forms a complex with ammonium molybdate in a sulfuric acid solution. The 
complexation of the phosphomolybdate with malachite green can be measured at 620nm and is 
directly related to ATP hydrolyzed by the Mss116p protein (bitesizebio.com). 
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For our reactions we pre-incubated 250nM Mss116p, rRNasin Inhibitor [1 U·µl-1] (Promega) with 
5µM BS12 ssRNA or 0.5µM ai5γ pre-RNA at 30°C for 10min. The reaction buffer mixture 
consisting of 55mM KCl (Ambion), 40mM HEPES pH 7.5 (AppliChem) and 0.85mM DTT and the 
samples were incubated at 30°C for another 10min. We started the reaction by adding an 
equimolar concentration of 1mM MgCl2 (Ambion) and ATP (AppliChem). At specific time points 5 
µl samples were withdrawn and diluted in a µCLEAR plate with 45 µl ddH2O. The reaction was 
stopped with 10 µl Malachite Green Reagent A to the 50 µl sample (10 min, room temperature). 
Then 10 µl Malachite Green Reagent B was added and the samples were incubated at room 
temperature finally the absorbance was measured with the Infinite F500 microplate reader at 
620nm. Results were evaluated with Excel. For controls we digested Mss116p with 0.5 µl 
Proteinase K (AppliChem) and RNA with 0.25 µl RNAse A at the first incubation step.  
 
1M DTT 
 154 mg Dithiothreitol  
Add 1ml ddH2O, resuspend, make 1:100 dilution and store at -20°C.  
 
ATP 
For preparation of ATP see chapter 2.2. 
Figure 29: The Malachite Green Assay Mechanism. It is based on the complexation of malachite green, 
ammonium molybdate and free inorganic phosphate (orthophosphate, Pi) in 3M sulfuric acid (bitesizebio.com; 
thanks to the author Megan Hogan). 
99 
6. In Vitro Metal Ion Cleavage Reactions  
 
6.1. Lead Cleavage Reactions 
We used 2pM of  full-length ai5γ RNA in 50mM MOPS pH 7.0 and 500mM KCl (Ambion), 
denatured the RNA for 1min at 95°C and let it cool at room temperature for 2min. 8mM MgCl2 
(Ambion) was added together with 250nM Mss116p and 1mM ATP (including 1mM MgCl2) and 
incubated at 30°C for 60min. Afterwards we added 5mM Pb(OAc)2 (Aldrich) to the reaction 
mixture and incubated it for 5min at 30°C. The protein was degraded with 0.5 µl Proteinase K 
(AppliChem) for 1min at room temperature. As a control we performed Pb2+-induced cleavage of 
D123456 RNA which was folded at optimal conditions: 0.5M KCl, 100mM MgCl2 and 42°C (high 
salt and temperature conditions promoting self-splcing). We precipitated the RNA with 1 µl 
glycogen [10 mg·ml-1], 20 µl 0.5M EDTA pH 8.0 (Ambion) and 2.5x vol. EtOH/0.3M NaOAc for 1 
hour at -20°C. We centrifuged samples at 4°C, at maximum speed for 1 hour and after drying the 
pellets were resuspended in 25 µl ddH2O. The sites of cleavage were mapped by reverse 
transcription (see chapter 4). 
 
6.2. Terbium Cleavage Reactions 
For in vitro Tb3+ cleavage reactions 50nM full-length ai5γ intron RNA (D123456) was denatured at 
95°C for 1 min in 40mM MOPS pH 7.5. After cooling samples at 30°C for 3min and a short spin 
we added 8mM MgCl2 (Ambion), 250nM Mss116p, KCl (Ambion) to a total concentration of 
100mM (depends on [KCl] in Mss116p storage buffer), 200 units rRNasin (Promega) and 1mM 
ATP (including 1mM MgCl2). The RNA-protein complex was formed by incubating the reaction for 
1 hour at 30°C. Subsequently different Tb3+ concentrations ranging from 1mM to 5mM Terbium 
(III) chloride (Sigma) were added to the sample. The tubes were placed on ice for 1 hour. After 
digesting the protein with 1 µl Proteinase K (AppliChem) at room temperature for 1 min, we 
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stopped the reaction with 25mM EDTA pH 8.0 (Ambion) and precipitated the RNA with 2 µl 
glycogen [10 mg·ml-1] and 2.5 x EtOH/0.3M NaOAc for 1 hour at -20°C. The pellets were 
resuspended in a final volume of 50 µl ddH2O and analyzed by reverse transcription (see chapter 
4). 
 
1M MOPS pH 7.5 
 20.9 g  MOPS 
Add ~ 70 ml ddH2O, adjust pH to 7.5 with KOH and bring volume to 100 ml with ddH2O, sterile 
filter and store at 4°C protected from light.   
 
0.1M Cacodylate buffer pH 5.0 
 1.07 g Sodium cacodylate trihydrate (Sigma) 
Dissolve salt in 20 ml ddH2O and adjust pH to 5.0 with HCl. Afterwards fill up to 50 ml with ddH2O 
and store at 4°C.  
 
ATP 
For preparation of ATP see chapter 2.2  
 
5M NaOH 
 10 g Sodium Hydroxide Pellets 
Fill up with ddH2O to 50 ml.  
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Results 
In order to map ai5γ group II intron structure in collapsed and native conformation at near 
physiological conditions in vitro, recombinant Mss116p had to be produced under native 
conditions, meaning that protein is soluble in supernatant after cell lysis and protein activity is 
preserved. Consequently the functionality of recombinant Mss116p was examined by means of 
an in vitro splicing assay, an unwinding assay and an ATPase assay. Once Mss116p functionality 
had been proven, we performed Pb2+ and Tb3+-induced cleavage reactions on the ai5γ intron 
under near-physiological conditions (8mM Mg2+ and 30°C) in the absence and presence of 
Mss116p. Metal ion cleavage reactions were extensively used before (147, 169) and on the basis 
of the described protocols we established in vitro  Pb2+ and Tb3+ cleavage reactions for mapping 
metal ion binding sites within the ai5γ intron.  
Producing Recombinant Mss116p 
Mss116p had been successfully crystallized in 2009 by Del Campo and Lambowitz (85). As our 
plasmid was a generous gift from Anna M. Pyle we established a protein purification protocol on 
the basis of information given by several publications coming from the Lambowitz and Pyle 
laboratories. Despite the information given in papers purification of Mss116p was a challenge, as 
detailed information about purification strategies and distinct steps were not indicated. Mss116p 
without mitochondrial localization sequence (Mss116p/∆MLS), deletion of mitochondrial 
localization sequence (79)) was produced as a fusion protein to a 6xHIS-tag as it has been sub-
cloned into a pET SUMO® expression system (pAS02 from (170)). Mss116p was overexpressed 
in Escherichia coli and expression was induced with IPTG. First optimal expression conditions 
had to be tested by studying protein expression and solubility at different growth parameters like 
temperature, IPTG concentration and incubation time.  
  
102 
1. Optimizing Protein Expression 
Induction of Mss116p/∆MLS Expression 
Mss116p/∆MLS expression has been performed by other groups at 16°C overnight (HIS-
Mss116p ∆MLS fusion and cleavage with SUMO protease) (38) or 15°C overnight (MalE-
Mss116p fusion and cleavage with TEV protease) (6). To confirm these parameters different 
temperature together with various IPTG concentrations and induction periods were analyzed. The 
combinations are illustrated in Table 2 and expression was found to be optimal with 0.5mM IPTG 
at 18°C and overnight growth in our hands as well. The amount of Mss116p/∆MLS was compared 
before and after induction with IPTG (at the specified incubation times and temperature) for the 
total extract as well as, in case of the induced aliquot, for the cell pellet and the supernatant 
(Figure 33). It is worth mentioning that the expression of Mss116p/∆MLS varies slightly between 
individual colonies, as shown in Figure 30, which displays the protein expression pattern of five 
different colonies induced under same conditions. In this case, colony 3 shows a slightly better 
expression pattern for Mss116p/∆MLS.  
 
Table 2: Parameters tested for protein expression, including IPTG concentration, temperature and time of growth.  
Temperature (°C) IPTG [mM] Growth (h) 
16 0.7 overnight 
18 5,1,0.7, 0.5, 0.25 3;4;overnight 
20 1, 0.5 overnight 
26 1 4 
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Figure 31 below illustrates three bacterial cultures where Mss116p/∆MLS was expressed under 
optimal conditions (0.5mM IPTG and overnight growth at 18°C).  
 
 
 
 
 
 
 
 
 
 
  
  
Figure 30: Testing five different colonies for induction parameters. Cells were induced with 0.25mM IPTG 
and grown at 18°C for 3 hours. Colony 3 shows best expression indicating that there is as well a slight 
difference in expression pattern with different colonies selected.  
Figure 31: Mss116p/∆MLS expression with 0.5mM IPTG and growth at 
18°C overnight. (-) cell lysate before induction; (+) cell lysate after IPTG 
induction; green arrow indicates Mss116p/∆MLS expression. 
104 
Figure 32: Testing protein sample quality over an in vitro splicing assay. Recombinant protein 
added to ai5γ pre-RNA (D123456) at near physiological conditions (8mM Mg2+ and 30°C) fully 
degrades RNA after 1 hour. Positive control indicates pre-RNA self-splicing under in vitro 
conditions (100mM Mg2+ and 42°C). 
2. Purification and Washing  
During our first trial the Ni-NTA column was sequentially washed with five cycles of Wash buffer I 
(including 50mM imidazole) after loading of the crude protein extract to remove nonspecifically 
bound proteins. While the control SDS-PAGE did not show any impurities within the 
Mss116p/∆MLS protein sample, substantial contamination with RNases was detected upon 
performing an in vitro splicing assay (Figure 32). Impurities completely degraded ai5γ precursor 
RNA within 1 hour (compared to the control reactions). The RNase activity could not be balanced 
by increasing the amount of RNase inhibitor. On the bright side, we also observed that the 
recombinant Mss116p/∆MLS was active, as indicated by the spliced intron in linear and lariat 
forms. Besides, the drawback of using higher RNase inhibitor concentrations is that storage 
buffer of the enzyme contains large amounts of glycerol, up to 50% (v/v). Together with the 
Mss116p/∆MLS storage buffer, which includes 10% glycerol as well, the final concentration of 
glycerol was greater than 10% in the enzymatic reaction, potentially inhibiting Mss116p/∆MLS in 
the metal ion-induced cleavage assay.  
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The majority of impurities were removed by additional washing cycles with increased imidazole 
concentration. Ni-NTA column was therefore sequentially washed with a) four cycles of Wash 
buffer I, including 50mM imidazole and subsequently by b) four additional washing steps with 
Wash buffer II which includes 100mM imidazole. Washing nickel-affinity column with Wash buffer 
II (Figure 33) removed small amounts of, presumably, Mss116p/∆MLS as well, but also further 
removed impurities which were not washed away with Wash buffer I. Applying these four 
additional washing steps significantly improved the purity of the Mss116p/∆MLS protein, such that 
only minimal RNA degradation was visible during the in vitro splicing assay (see Figure 39). 
 
RNases Expressed by BL21 
A ‘Uniprot’ database query of RNAses expressed in the E. coli BL21 strain revealed several RNA 
degrading proteins which have similar size as Mss116p/∆MLS and also harbor numerous 
histidines within their protein sequence. Exoribonuclease 2 for example which is highlighted in 
grey in Table 3 carries 12 histidine residues, with a size of 72.4 kDa and exactly same amino acid 
sequence length as Mss16p/∆MLS which carries as well 12 histidine within protein sequence. 
Over using Centrifugal Devices like in our case the 30K cut-off device was able to exclude 
impurities with a molecular size smaller than 30 kDa e.g. the Ribonuclease HII which has a size 
Figure 33: Illustrating protein purification steps and protein levels within cell pellet (CP), Supernatant after clarifying lysate 
over centrifugation (SN) and the flow through after incubating Ni-NTA resin with cleared lysate (FT). Green arrows: indicate 
Mss116p/∆MLS levels; Red arrows: illustrate impurities. 
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of 21.5 kDa. To remove remaining RNases a gel filtration experiment should therefore be 
performed to obtain higher protein quality. 
 
Table 3: Abridgment of Uniprot query of RNAses expressed by E. coli strain B/ BL21-DE3. The table indicates accession 
number of the protein, number of histidines in protein sequence (HIS), protein size in Dalton and amino acid sequence 
length (AA).  
Accession Protein names Gene names HIS Size DA Length AA 
C6ECH0 Exoribonuclease R, RNase R (EC 3.1.-.-) (VacB and RNase II family 3'-5' exoribonuclease) (EC 3.1.13.1) rnr ECBD_3855 ECD_04046 18 92.109 813 
C6EFU6 Exoribonuclease 2 (EC 3.1.13.1) (Exoribonuclease II) rnb ECBD_2331 ECD_01263 17 72.476 644 
C6EHC9 Fused ribonucleaseE: endoribonuclease/RNA-binding protein/RNA degradosome binding protein (EC 3.1.4.-) (Ribonuclease, Rne/Rng family) rne ECBD_2516 ECD_01080 24 118.287 1061 
C6EAA2 Ribonuclease HII (RNase HII) (EC 3.1.26.4) rnhB ECBD_3436 ECD_00181 8 21.543 198 
C6EBY5 Exodeoxyribonuclease X (EC 3.1.11.-) (Exonuclease RNase T and DNA polymerase III) exoX ECBD_1796 ECD_01815 8 25.115 220 
C6EK20 Ribonuclease 3 (EC 3.1.26.3) (Ribonuclease III) rncS rnc ECBD_1114 ECD_02461 7 25.550 226 
C6EF15 Ribonuclease BN rbn ECBD_4141 ECD_03771 2 32.839 290 
C6EK83 Enterobacter ribonuclease (EC 3.1.27.6) (Ribonuclease I) (EC 3.1.27.6) rna ECBD_3041 ECD_00579 4 29.618 268 
C6E9T1 Ribonuclease Z (RNase Z) (EC 3.1.26.11) (tRNA 3 endonuclease) (tRNase Z) elaC rnz ECBD_1390 ECD_02195 12 32.930 305 
C6EGL4 Ribonuclease G (EC 3.1.4.-) (Ribonuclease, Rne/Rng family) rng ECBD_0500 ECD_03106 13 55.364 489 
 
 
Removing Remaining Impurities By Gel Filtration 
Solem et. al 2006 and Del Campo and Lambowitz 2009 (38, 85) performed a gel filtration as a 
final step before dialysis to remove remaining impurities. In collaboration with Kristina Djinovic-
Carugo and co-workers a gel filtration using a Hiload Superdex-200 column was performed. Gel 
filtration though was not successful as protein came off in very late elution fractions which could 
not be collected. This might have happened due to high glycerol and/or salt conditions and as a 
result the protein molecules formed aggregates resulting in precipitation. Thus, filtration 
conditions would have to be adjusted in a very time-consuming process. Meanwhile, we had done 
some activity assays with the Mss116p/∆MLS prepared with stringent washing steps. As the 
purity of the protein preparation seemed to be sufficient for successfully performing the activity 
assays, in which we only observed a minimum of RNA degradation (Figure 39), we refrained from 
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processing with optimizing the gel filtration set up. However, as gel filtration is known to improve 
the purity of recombinant protein preparations, this leaves of course room for further improvement 
of the quality of our Mss116p/∆MLS preparations. 
 
3. Preparing untagged Mss116p/∆MLS 
For producing recombinant protein six consecutive histidines and a protease cleavage site were 
introduced to the N-terminus of Mss116p. His tags bind selectively to nickel-affinity columns and 
tag can be is removed by a protease, requiring an additional purification step to eliminate the 
cleaved tag (~13kDa) afterwards. To facilitate protease cleavage of Mss116p/∆MLS Solem et al. 
added an N-terminal serine to Mss116p/∆MLS (38). Unexpectedly, removal of the 6x-His tag 
decreased the solubility of Mss116p/∆MLS. Thus, the final purification conditions have to be 
adjusted to avoid aggregation and in turn precipitation of untagged Mss116p/∆MLS protein. Del 
Campo and Lambowitz added 10% glycerol and L-arginine and L-glutamate to increase protein 
solubility from 1 mg·ml-1 up to 10 mg·ml-1 (85).  
 
Cleaving off the 6x-His Tag  
As mentioned before, the construct contains a cleavage site for the SUMO protease between the 
6x His tag and the Mss116p/∆MLS sequence. The SUMO protease is a cysteinyl protease (Ubl-
specific protease 1) from S. cerevisiae and cleaves highly specific by binding to tertiary structure 
of ubiquitin-like protein, SUMO rather than to specific amino acid sequence (Invitrogen). 
Performance of the SUMO protease is optimal at 30°C; therefore the cleavage was tested in a 
time-dependent manner at this temperature. At 30°C cleavage was completed after 3 hours of 
incubation (Figure 34). Performing the cleavage overnight at 30°C has no additional positive 
effect on removing the tag.  
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Additionally, SUMO-protease cleavage was performed at 4°C overnight, as suggested by Solem 
et al. 2006. The cleavage reaction at 4°C was slightly less efficient than at 30°C (compare Figure 
35). Since washing and elution steps during purification of the recombinant Mss116p/∆MLS 
protein were performed at 4°C, we 
decided to apply the same temperature 
for the SUMO-cleavage step as well, 
offering constant low temperature 
conditions, which might be favorable 
for protein stability. To this end, the tag 
was cleaved off by the SUMO protease 
at 4°C overnight.  
 
 
  
Figure 34: Tag cleavage at 30°C for 3, 5 hours and overnight. Reaction 
mixture was split in two parts (tube 1 and 2) to reach a maximum of 2ml 
reaction volume. Full cleavage can be already observed after 3 hours at 
30°C. Red arrow indicates cleaved tags with an approximate size of 13 kDa.  
Figure 35: Tag cleavage at 4°C overnight and subsequent purification 
steps. Precipitate was removed over centrifugation. Protein was 
concentrated with 30K Centrifugal Devices and dialyzed against 
storage buffer. (SN) visualizes cleared untagged protein without 
precipitate. 
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Increasing Protein Solubility Over 10% Glycerol, L-Arg and L-Glu 
After cleavage of fusion protein, precipitation of the untagged Mss116p/∆MLS was observed at 
both reaction temperatures, 4°C and 30°C, respectively. The precipitate was analyzed on SDS 
PAGE and showed that ~60% of recombinant protein Mss116p/∆MLS was precipitated after 
removal of the tag (Figure 36). Therefore, following the Lambowitz and coworkers (85), we tried 
to increase the solubility of untagged Mss116p/∆MLS by adding 10% glycerol, 50mM L-arginine 
and 50mM L-glutamate to SUMO protease cleavage reaction. Figure 36 illustrates precipitation of 
protein before addition of additives where we calculated protein levels over ImageQuant. Only 
40% of protein could be collected in the supernatant. After adding supportive agents protein 
solubility could be increased to ~ 65% which can be seen in lane SN of Figure 35.  
 
 
 
 
 
 
 
 
 
Removal the Cleaved Tag and the SUMO Protease  
At the beginning, we reasoned that by loading the SUMO cleavage reaction on the Ni-NTA 
column, the cleaved tag as well as remnants of tagged Mss116p/∆MLS would remain on the 
matrix, while the untagged Mss116p/∆MLS would be in the flow through. However, the untagged 
Mss116p/∆MLS did not come off the column due to its 11 histidine residues dispersed over its 
primary sequence. Consequently, we tried to elute the untagged protein with increasing imidazole 
Figure 36: Protein precipitation after tag cleavage. ~60 % of 
untagged protein precipitates after SUMO cleavage. (SN) 
supernatant after removing precipitation by centrifugation; 
(Prec.) Precipitate resuspended in adequate volume.  
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or KCl concentrations, hoping that the untagged protein would come off the column at a different 
concentration compared to the tagged one and the cleaved tag. However, only very low levels of 
protein could be collected. Checking an aliquot of column material on SDS PAGE revealed that 
most of protein was still bound to the resin. Elution with buffers containing between 50mM and 
500mM imidazole or between 0.5 and 1M KCl was not effective at all (Figure 37). Protein is 
hardly removable from resin neither by an imidazole nor a high salt gradient. In a different 
approach we tried to cleave off protein directly from the column resin after the washing steps. The 
result showed similar results as in the previous experiment where Mss116p/∆MLS was tightly 
bound over its exposed histidines to the nickel-charged resin and not removable over high 
imidazole and salt gradients. 
 
 
 
 
 
  
 
 
In fact it is tempting to suggest that there might be a structural change after tag cleavage which 
increases protein affinity for the nickel-charged resin. However, another explanation would be that 
Mss116p/∆MLS is not traversing a structural change but gets tightly bound by several other 
exposed histidines on its protein surface (w/t Mss116p carries 12 histidines in protein sequence 
and Mss116p/∆MLS carries 11 histidine residues). And in fact, checking location of histidines in 
crystal structure (Mss116p/Δ598-664) (86) revealed that most of the 11 histidines are exposed on 
the surface (Figure 38).  
Figure 37: elution with increasing imidazole concentration ranging from 
50mM to 500mM. Elution fractions 200mM and 250mM indicate major 
removal of fusion tags. Lane ‘column’ indicates that majority of protein is 
still bound to nickel-charged resin 
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As a result 30K centrifugal devices were used in order to remove the tag (consisting of 6x His and 
cleavage site for SUMO protease) and the SUMO protease, which have an approximate size of 
13 kDa and 26 kDa, respectively (lifesensors.com). Protein degradation fragments and RNases 
smaller than 30 kDa (see Table 2) are removed by centrifugation as well. Additionally, a twofold 
increase in protein concentration could be achieved (Figure 35) resulting in a protein yield ~1mg 
per liter of culture.  
 
  
Figure 38: Mss116p/Δ598-664 crystal structure (green) 
complexed with ssRNA (orange) and AMP-PNP (yellow). 
Histidine residues were highlighted in white using PyMOL 
showing that most of them protruding from the surface. Mg2+ is 
indicated as a red sphere.   
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Protein Activity Assays 
 
Mss116p-Promoted Splicing Activity of Ai5γ pre-RNA 
Mss116p promotes splicing of ai5γ group II precursor RNA, resulting in the appearance of ligated 
exons and intron lariat with a rate constant kobs 
of 30 x 10-3 – 35 x 10-3 min-1 (6). To show that 
the recombinant Mss116p/∆MLS, which we 
prepared, is able to promote splicing with 
similar activity, we established a protocol on 
basis of  previously published splicing assays 
(6). A minimum of 6mM Mg2+ is required for the 
observing Mss116p-stimulated ai5γ splicing  
and this activity is observable up to 35mM 
Mg2+, while concentrations above 35mM inhibit 
Mss116p in its ability to promote intron splicing 
(38). Indeed, at near-physiological conditions 
(30°C; 8mM MgCl2, 100mM KCl, 40mM MOPS 
[pH.7.5]) Mss116p-mediated self-splicing was 
observed to generate the same reaction 
products, as self-splicing promoting at high-salt 
conditions (42°C, 100mM MgCl2, 0.5M NH4Cl) (38). As illustrated in Figure 39 recombinant 
Mss116p/∆MLS efficiently promotes splicing of Sc. ai5γ group II intron plus 1mM ATP. 
Comparable to the optimal splicing conditions, after 120 min almost all of the pre-RNA has been 
converted into spliced introns, in both linear and lariat forms, and ligated exons in the presence of 
Mss116p/∆MLS as well. On the contrary, little splicing is observed at near-physiological 
Figure 39: Protein-mediated splicing of Ai5γ. Self-splicing 
reactions under high-salt and temperature conditions (in 
the absence of Mss116p) (+) and Mss116p-assisted intron 
splicing at near physiological conditions. (-) The negative 
control shows lack of splicing at near physiological 
conditions in the absence of Mss116p. I-Lin may contain a 
mixture of linear intron and broken lariat intron RNA. 
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conditions and in the absence of Mss116p/∆MLS. The gel was quantified with ImageQuant and 
data was fit to a single turnover equation using the program KaleidaGraph. Figure 40 illustrates 
the precursor RNA levels plotted with respect to time and quantification revealed a comparable 
rate constant of kobs of 30 ± 0.009 x 10-3 min-1. Despite these positive results, it has to be 
mentioned that there is still significant amount of degradation of precursor RNA, spliced introns, 
ligated exons and free 3’- and 5’ exon taking place in reactions containing Mss116p/∆MLS. This 
is mainly caused by RNases that are still present in the recombinant protein Mss116p/∆MLS 
preparation.  
 
  
Figure 40: in vitro preRNA splicing by Mss116p/∆MLS at near-physiological 
conditions. To evaluate the rate constant of splicing reaction the gel was quantified 
with ImageQuant and data was fit to a first-order rate equation with KaleidaGraph 
(has been described by (5)). A rate constant kobs of 30 ± 0.009 x 10-3 min-1could be 
calculated which is comparable to earlier kinetic studies on Mss116p (6). m1: value 
at time point 0; m2: kobs, rate constant; m3: amplitude; R: correlation coefficient. 
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ATPase Coupled Unwinding of Short Duplex RNAs 
Mss116p was shown to perform unwinding activity of short duplex RNA oligonucleotides (6-16 
bps) in the presence of ATP with a rate constant kATP of 4.9 ± 1.1 (x109 M-1 min-1) (6). Reactions 
were carried out at saturating Mss116p conditions and rate constants for blunt end duplexes had 
been shown to be similar to that of duplexes with a 3’ or 5’ overhang. It is estimated that a 
minimum of 1.4 ATP molecules are necessary for strand displacement (171). For showing 
Mss116p duplex-unwinding, reactions were performed on the basis of previously published 
protocols (6, 38). Mss116p/∆MLS showed no unwinding activity with reactions including 0.1nM 
duplex, 400nM Mss116p at 100mM KCl, 40mM MOPS pH 7.5, 2mM DTT, 0.01%IGEPAL 
conditions started with 4mM MgCl2/ATP mix.  
 
 
 
 
 
 
 
 
 
As reaction should not include magnesium concentrations greater than 1mM (6), because Mg2+ 
ions stabilize RNA duplexes and decrease functional binding of Mss116p, a 1mM MgCl2/ATP mix 
was used. Again no unwinding activity was detectable. Subsequently, we modified the protocol 
according to the recently published unwinding protocol by Jankowsky and Putnam 2010 (68). To 
prevent reformation of  duplex after unwinding we tried to capture the labeled complementary 
strand after unwinding by adding a 2000-fold molar excess of unlabeled top strand directly into 
Figure 41: 12mere blunt end duplex in the absence and presence of 
Mss116p. (DS) 12mere duplex serving as a negative control; (SS) heat 
denatured control indicating position of labeled single strand. Unwinding 
was performed at 30°C and reaction started with 1mM MgCl2/ATP. 
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unwinding reaction mixture. Additionally reaction was stopped with an increased amount of EDTA 
(from 50mM up to 200mM) and withdrawn aliquots were immediately put on ice or, alternatively, 
loaded immediately on a running native gel. However, unwinding could not be detected with 
either protocol (Figure 41). As a result, it is uncertain whether our Mss116p/∆MLS preparation is 
capable of unwinding short duplex RNAs or if the problem resides in how we perform the 
unwinding assay. After personal communication with Dr. Fedorova (Yale University), who is 
familiar with this type of assay and Mss116p, performing an unwinding assay with Mss116p is 
everything but trivial. In other words, it is likely that our preparation will be active in unwinding and 
the assay needs further troubleshooting and experience to be successfully performed.   
 
RNA-Dependent Activation of Mss116p ATPase Activity 
RNA enhances the slow intrinsic ATPase activity of Mss116p ~7 fold by accelerating rate limiting 
ATP hydrolysis (171). The ATP hydrolysis of Mss116p progressively increases with increasing 
amounts of RNA bound to protein and at saturating ATP concentrations Mss116p shows different 
ATPase activity for different RNAs (6). For Sc. ai5γ ATPase activity was measured with a kobs of 
112 ± 6 (min-1) and no activity was detectable in the absence of RNA (6). For determining the 
RNA-dependent ATPase activity of Mss116p/∆MLS in vitro, the concentration of the free 
inorganic phosphate was measured by complexation with malachite green and ammonium 
molybdate under acidic conditions. The centration of this complex can be measured at 620nm 
and is directly related to levels of ATP hydrolyzed by Mss116p/∆MLS. Reaction conditions were 
chosen on basis of previous published protocols (6, 38). Nevertheless, the initial protocol had to 
be optimized due to the occurrence of precipitate in reaction mixture. Consequently, we diluted 
the reaction volume 1:10, thereby improving the stability of the assay and decreasing the amount 
of precipitate. Furthermore, the Mss116p/∆MLS protein had to be hydrolyzed or inactivated 
before measurement (suggested by manufacturer). To hydrolyze the Mss116p/∆MLS protein it 
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was suggested to heat the reaction mixture at 100°C for 30min. However, incubating ATP at 
temperatures above 56°C in the presence of Mg2+ induces its hydrolysis as well. Therefore, we 
modified the manufacturer’s instructions and tried to degrade protein with denaturing agents. First 
proteinase K was added but caused substantial precipitation within reaction. Proteinase K storage 
buffer includes 40% glycerol and DTT, which both reduce the sensitivity of reaction. In a different 
approach EDTA (10mM) was used to stop ATP hydrolysis by Mss116p/∆MLS, but adding EDTA 
caused precipitation as well. At next we used β-mercaptoethanol to terminate ATP hydrolyzing 
reaction by Mss116p/∆MLS. Again, this substance had a negative effect causing precipitation in 
the reaction mixture. Screening the literature we found in an earlier publication that proteins must 
be removed or stabilized prior to Pi determination with 0.25N sulfuric acid or 3% (w/w) perchloric 
acid (172). As Malachite Green Reagent 
A contains 3M sulfuric acid, we assumed 
that no specific step to stop the reaction 
was necessary. Indeed, we successfully 
tested this hypothesis and proceeded 
with the assay.  
The ATPase activity of Mss116p/∆MLS 
was determined in the absence of RNA 
as well as in the presence of a short 
single-stranded RNA (12mer) and the 
large, full-length ai5γ intron RNA at 30°C, 
pH 7.5 and the presence of 500mM KCl 
and 10mM MgCl2. Plotting the fraction of 
Pi (and in turn of ADP) as a function of time, we derived observed rate constants kobs of 0.132; 
0.039 and 0.016 (min-1) in the presence of full-length ai5γ intron RNA, of 12mere RNA 
Figure 42: ATP hydrolyzed by Mss116p. (A) black: ATP hydrolysis 
without Mss116p; green: ATP hydrolysis in the presence of 
Mss116p; red: ATP hydrolysis in the presence of Mss116p and 
12mere RNA; blue: hydrolysis by Mss116p in the presence of ai5γ 
full length intron. (B) Illustrating reaction parameters. m1: value at 
time point 0; m2: kobs, rate constant; m3: amplitude; R: correlation 
coefficient 
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oligonucleotide and without RNA, respectively. In the presence of full length ai5γ Mss116p/∆MLS 
shows ~8 fold higher ATPase activity than in the absence of RNA. The presence of a 12mer RNA 
oligonucleotide enhances the ATPase activity of Mss116p/∆MLS by ~2.4 fold (Figure 42). This is 
in excellent agreement with previously published data (6, 171). 
 
Towards Assessing the Influence of Mss116p on Metal Ion Binding Sites in the 
Collapsed Ai5γ Intron 
Established a metal-induced cleavage assay – Pb2+ and Tb3+ Cleavage Reactions 
At first, to examine optimal concentration range for performing Lead-induced cleavage reactions a 
concentration series from 1mM to 5mM was performed on the full-length ai5γ intron RNA folded at 
high-salt conditions (known to promote self-splicing). Cleavage reactions with 5mM Pb(OAc)2 
showed best results and therefore this concentration was chosen for subsequent metal-ion 
induced cleavage reactions. Importantly, since the intron RNA is rather large (886 nts) and we 
aimed to compare our results with those from studying metal ion binding sites in vivo using Pb2+-
induced cleavage (173), the cleavage sites were mapped using primer extension analysis. Thus, 
a control in which RNA that was not cleaved by lead was reverse transcribed, was performed to 
distinguish between natural stops of the reverse transcriptase and lead-induced stops. However, 
numerous RT-stops were observed in this negative control in the absence of lead (0mM Pb2+). 
Therefore entire lead-induced cleavage assay including the primer extension protocol had to be 
optimized to reduce background. First, cleavage reactions were quenched with an increased 
amount of EDTA (from 100mM to 200mM) but had no positive effect on RNA stability. Checking 
pH of reactions in the presence and absence of Pb2+ revealed a pH of 7.0 in all mixtures 
excluding the possibility that an increased pH could have caused adverse effects in the negative 
controls. An increased amount of RNase inhibitor within reaction mixture did not improve the data 
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as well. With increased experience, I was able to detect metal ion binding sites within D1 of the 
full length intron (Figure 43). Weak Pb2+ cleavage could be observed close to the θ interaction 
site, around nucleotides A125-A128 and at the A139 in the internal loop of the D1c2 branch. 
Stronger Pb2+ cleavage could be detected at the λ and ε’ regions in the D1c1 stem and within the 
regions flanking the β element.  Despite the difficulties with the assay, the observed sites 
correlate nicely with previously published data (126, 147). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As Tb3+ has a smaller ionic radius (0.92 Å) than Pb2+ (1.20 Å), it has been of advantage to use 
terbium as a probe due to its radius being closer to that of Mg2+ (0.72 Å) (147). Therefore, we 
decided to switch to a Tb3+-induced cleavage assay to improve the signal-to-noise ratio when 
mapping the cleavage sites by reverse transcription. To examine optimal Tb3+ concentration for 
cleavage reactions different concentrations 1, 2.5, and 5mM were tested. It could be observed 
Figure 43: Pb2+ cleavage reactions within D1. Schematic views lead cleavage sites within full length 
ai5γ intron under high-salt conditions (100mM MgCl2, 500mM KCl and 42°C) which were visualized 
over reverse transcription with end labeled Sc160 primer and resolved on an 8% polyacrylamide gel. 
Strong cleavage occurs around ε’ and λ regions in the D1c1 stem 
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that cleavage with 5mM Tb3+ caused increased degradation of RNA and is therefore not suitable 
for in vitro cleavage reactions (data not shown). At last we decided to simply try and compare 
metal ion binding sites at near-physiological conditions in the absence and presence of 
Mss116p/∆MLS (Figure 44). It is evident that only very few cleavage sites were observed and not 
significant differences are visible between the reactions with or without Mss116p/∆MLS. By 
performing the metal-induced cleavage reactions at lower temperature (4°C for 1 hour) and using 
snap cooling during reverse transcription only showed only a minor improvement in mapping the 
cleavage sites by primer extension.  
As a result only a few cleavage sites could be detected over Tb3+ cleavage reactions (Figure 44). 
Cleavage was observed at nucleotides A155-A157 near β interaction site. Weak cleavage was 
observed as well at position A339 and A351, but cleavage sites are ambiguous, as they are only 
clearly visible in reactions containing 2mM Tb3+. Within EBS1 RNA degradation can be observed 
within all reactions and are caused by the addition of Mss116p/∆MLS. In other words the 
problems are multi-fold. On the one hand, Mss116p/∆MLS preparation still contains some 
RNases and, second, working with such a large complex RNA like the ai5γ intron requires a lot of 
experience to avoid a strong background in the negative control of the primer extension (0mM 
Tb3+ lanes), making it difficult to map metal-induced cleavage sites. In sum metal-induced 
cleavage reactions are in need of further improvement to map metal ion binding sites within the 
ai5γ intron by reverse transcription.  
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Figure 44: Tb3+ cleavage site throughout D1 of full length ai5γ ribozyme. 
Each schematic views cleavage pattern in collapsed (-Mss116p) and native 
intron conformation (+Mss116p). 
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Discussion 
We expressed the yeast DEAD-box protein Mss116p in E. coli and characterized the biochemical 
activity of the purified protein. The recombinant Mss116p/∆MLS protein was active and promoted 
intron splicing and hydrolyzed ATP comparable to previous reports (6, 171). Afterwards we 
attempted to map metal ion binding sites within the ai5γ group II intron was mapped over by 
performing a metal ion cleavage reaction in the absence and presence of Mss116p/∆MLS under 
near physiological conditions, yielding the collapsed and native intron structure in vitro, 
respectively. It was our goal to examine whether Mss116p is able to take over the role of Mg2+ 
ions in certain structural elements of the intron. However, due to time constraints as well as the 
inherent difficulty of successfully applying this approach to large RNAs, additional experiments 
are required to determine whether Mss116p indeed influence metal ion binding sites in vitro. 
These data are then compared with those metal ion binding sites observed previously in the 
native ai5γ intron conformation in vitro (147) as well as with those found in vivo in the spliced 
intron which maintains is functional conformation (80, 173). This comparison allows us to 
determine whether Mss116p facilitates formation of the folding control element, which is captured 
by Mg2+ ions in vitro at high salt conditions and in the absence of Mss116p, and in turn 
accelerates the rate constant for the collapse (41, 126, 173). 
 
Producing Recombinant Mss116p/∆MLS 
Purification of untagged Mss116p/∆MLS posed numerous challenges, like eliminating unwanted 
impurities as well as stabilizing the protein after removing the tag and preserving protein activity. 
The majority of impurities could be removed by applying more stringent washing steps including 
increased imidazole concentrations to an extent that subsequent assays requiring high levels of 
RNA and its stability could be performed and. The second challenge was to stabilize protein and 
preserving its native structure. After the tag has been cleaved off, the protein precipitated; this 
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adverse effect could be largely diminished by adding 10% glycerol, L-arginine and L-glutamate 
during the SUMO cleavage reaction. Together with an N-terminal serine, which was inserted into 
sequence protein solubility can be increased (Invitrogen). After removing the affinity tag the 
untagged Mss116p/∆MLS protein exposed a significant affinity for the nickel-charged resin and 
was hardly removable by imidazole and high salt gradients. A tempting point of view is now that 
such affinity tags can have an effect on structure and function of the protein (174). Comparative 
studies from tagged and untagged protein structures revealed however only minor structural 
differences and these differ from protein to protein (175). Also, it has been found that C-terminal 
His-tags have more frequently a negative effect on protein solubility than N-terminal His-tags 
(176), suggesting that tag has no profound effect on Mss116p native structure. A reason for the 
high affinity to nickel-charged resin therefore might be that protein gets tightly bound to the matrix 
through its 11 histidines dispersed within its primary sequence where most histidines residues are 
exposed at the protein surface. For future studies we suggest optimization of gel filtration to 
further improve protein quality.  
 
Is the recombinant Mss116p/∆MLS Protein Active? 
We showed that untagged Mss116p/∆MLS promotes group II intron splicing reactions at near 
physiological conditions in an ATP-dependent manner comparative to activity determined in 
earlier studies (6). However, slight RNA degradation is still observed during assays due to 
RNases present in the protein preparation. To further improve the splicing assays we suggest 
slightly increasing the amount of RNase inhibitor (<10% of glycerol v/v) or improving quality of the 
Mss116p/∆MLS protein sample by applying a gel filtration prior to dialysis. In spite of the 
successful stimulation of intron splicing, unwinding of short RNA duplex by our untagged 
Mss116p/∆MLS preparation in the presence of ATP could not be detected. In a previous study a 
rate constant kATP of 4.9 ± 1.1 (x 109 M-1 min-1) was measured for a 16mer blunt-end substrate 
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(6). Like many other DEAD-box proteins, Mss116p does not display a preference for single 
stranded RNA regions or particular orientations therefore a 12mer blunt-end substrate was 
chosen in our unwinding studies (38). The rate constant should be even higher as activity 
increases with shorter duplexes (6). Notably, Mss116p and other DEAD-box proteins are known 
to be poor, non-processive RNA helicases (68). However, it has been proposed that because 
Mss116p unwinding is coupled with ATP and RNA binding, this raises the possibility that ATP 
binding can promote local unwinding of the bound duplex RNA, suggesting a coupled mechanism 
between ATP and RNA binding (171). Consequently, the lack of unwinding activity could simply 
imply the need for further optimization of the activity assays. Secondly, it remains possible that 
Mss116p could also be inactivated by impurities, which are present in the protein preparation and 
which block RNA or ATP binding activity. Interestingly, Mss116p/∆MLS displayed an ATPase 
activity, which is ~8 fold increased in the presence of full length ai5γ intron RNA. Cao et al. 
revealed that RNA accelerates the Mss116p steady-state ATPase activity ~7 fold by promoting 
rate-limiting ATP hydrolysis (171). Current models suggest that Mss116p bound to ATP and ADP-
Pi strongly binds and reorganizes RNA structure; Pi release promotes weak RNA binding, thereby 
dissociating the complex and allowing intron self-splicing and regenerating free Mss116p for 
additional rounds of catalysis (81, 157, 171). For Mss116p and DbpA, the ATPase cycling is 
completely characterized at kinetic and thermodynamic level and the reaction pathway seems to 
be a conserved one (171). Therefore additional mechanistic details of kinetic and equilibrium 
constants of wild-type Mss116p are could be helpful in understanding Mss116p-promoted intron 
splicing.  
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Mapping Metal Ion Binding Sites within the ai5γ Intron 
D1 of ai5γ group II intron harbors several important long-tertiary interactions as well as secondary 
structure elements like bulges. The β-β’ interaction between positions G145-G149 in the c2 stem 
and C254-C259 at d2a is known to be important during intron compaction (126).  We observed 
Pb2+-induced cleavage at residues close to the β element within the natively folded ai5γ intron 
(D123456) supporting the probable presence of a metal ion pocket. This correlates well with the 
weak Tb3+ cleavage observed at residues flanking the β region and medium to strong Tb3+ 
cleavage at nucleotides flanking β’ region within the D135 ribozyme folded to the native state in 
vitro (147). Thus, the presence of D2 and D4 in the D123456 construct (compared to D135) has 
no influence on this particular metal ion binding site. In contrast, recent in vivo lead cleavage 
assays (Wildauer & Waldsich, unpublished) did not detect cleavage within the β-β’ intra-domain 
interaction in the presence of Mss116p. This potentially indicates an influence of the Mss116p 
protein on this metal ion binding site. Similarly, weak lead cleavage was detected close to the θ 
interaction site in both D135 (147) and D123456 ribozymes, while cleavage sites were not visible 
in vivo (80) . The θ-θ’ tetraloop-receptor interaction is suggested to play a role in stabilization of 
the intron core and in recruiting the catalytic effector D3 together with J2/3 to the active site (128). 
Additional Pb2+ cleavages were detected around ε’ and λ regions in the D1c1 stem of the native 
ai5γ intron (D123456), which had been also observed in the native D135 ribozyme (147) . The 
subdomain IC1 of D1 has been proposed to serve as a first-step-specific RNA receptor for the 
branchpoint-carrying D6 substructure and conserved elements like the ε-ε’ and λ-λ’ interaction 
(177) and therefore represents a highly interesting domain element (123). While no lead-induced 
cleavage was observed at the ε‘ and λ sites in vivo, cleavage within Jc1/c2 was detected in vivo 
as well (173).  
Since the Pb2+-induced cleavage had a low signal-to-noise-ratio, we tried to improve the data by 
employing Tb3+ cleavage to map the metal ion binding sites within the ai5γ intron in the absence 
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and presence of Mss116p, thereby shedding further light on its mechanism of action. However, 
this endeavor was not very successful, as in vitro the cleavages might be hidden due to high RNA 
degradation (even in the absence of Mss116p). Due to the time constraints this project remains to 
be finished (see outlook below). At last, it is noteworthy to mention that some metal-ion binding 
sites might remain undetected mainly within RNA helices (major groove of G-C rich duplexes or 
GU wobble pairs). This is inherent to the assay, as Pb2+ and Tb3+ mediate RNA hydrolysis 
through the formation of hydroxides, which cleave RNA dependent on geometry (2’OH in minor 
groove) (147, 148). Additional biochemical characterization of Mss116p-K158E protein, which 
carries a mutation in the ATPase active site, thereby showing no detectable ATPase activity, 
would be a further step as well as mapping the structural effect of the ATP-deficient mutant to the 
ai5γ group II intron. 
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Conclusion and Outlook 
With my work I offered a purification protocol for recombinant Mss116p, biochemical assays to 
validate Mss116p activity and set the first milestone for metal-ion cleavage reactions in vitro. 
Visualizing cleavage sites by reverse transcription is very sensible and requires as little as 
possible of background RNA degradation. As a matter of fact many cleavages may remain 
undetected and at this point there is significant room for improvement. Also, it might be worth 
considering to map the metal-induced cleavage products directly by end labeling of the full length 
intron, as it has been done in previous studies with the truncated ai5γ group II ribozyme (D135) 
(126, 147). Notably, mapping the full length ribozyme using end labeled RNA is a challenge due 
to the size of the full-length intron, which is likely to result in the need of an internal site-specific 
label of the intron to be able to map the entire RNA. In any event, to understand the role of 
Mss116p during the intron collapse, it is necessary to study the metal ion binding sites in the 
collapsed ai5γ intron in the absence and presence of Mss116p in order to determine whether 
Mss116p compensates for the high Mg2+ requirements during compaction, e.g. by facilitating 
formation of the folding control elements, which is very slow even at high salt and then captured 
by Mg2+ ions, and in turn accelerating the collapse. Since in vivo the metal ion binding sites in the 
presence of Mss116p are very similar to those observed in vitro for the native D135 ribozyme, 
this implies that Mss116p does not influence metal ion binding in the native ai5γ intron. Thus, in 
the  future it would be highly interesting to either produce recombinant Mss116p carrying the 
K158R mutation to study metal ion binding sites within the collapsed ai5γ intron that remains 
bound to the ATPase-deficient Mss116p mutant in vitro or to apply the in vivo Pb2+-cleavage 
assay to a yeast strain encoding the K158R Mss116p variant.  
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Abstract 
The self-splicing Sc. ai5γ group II intron has long been a powerful and representative model to 
study RNA folding in vitro. Like for other RNAs, metal ions play an essential role for ai5γ folding in 
vitro and in yeast mitochondria. In contrast to the intracellular ionic concentrations, the ai5γ intron 
depends on high salt conditions for splicing in vitro. Specifically, compaction is limited by the 
formation of an unstable folding intermediate that is captured by the binding of Mg2+. Mg2+ ions 
are known to play a crucial role in promoting the slow collapse of the ai5γ ribozyme in vitro. It has 
however been observed that the nuclear-encoded DEAD-box helicase, which serves as a splicing 
factor for all yeast mitochondrial introns, is able to lower the Mg2+ requirements in vitro to near 
physiological concentrations. Since Mss116p has recently been described to accelerate the 
compaction of the ai5γ intron in vitro, we are interested in understanding whether Mss116p is able 
to stimulate intron folding by stabilizing the unstable, rate-limiting folding intermediate. The first 
step to accomplish this goal was to produce recombinant Mss116p protein. After establishing an 
appropriate expression and purification protocol for Mss116p we analyzed whether the 
recombinant protein is active. In particular, we demonstrated that the recombinant Mss116p is 
capable of hydrolyzing ATP stimulated by RNA and it promoted group II intron self-splicing at 
near-physiological ionic and temperature conditions, leaving little doubt to be a fully functional 
protein. At last, we established a method to probe the ai5γ intron structure in the absence and 
presence of Mss116p in vitro employing a metal ion-induced cleavage assay. Our preliminary 
data suggest further optimization of the Tb3+ induced cleavage assay is necessary in order to 
map metal-induced cleavage sites by means of reverse transcription and eventually to 
understand the role of Mss116p in the collapse of the ai5γ intron.  
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Zusammenfassung 
Das selbst-spleißende Sc. Gruppe II Intron ai5γ stellt seit Langem ein überaus wichtiges und 
mächtiges Modelsystem für RNA Faltung in vitro dar. Wie für alle anderen RNAs, spielen Metall 
Ionen eine entscheidende Rolle im ai5γ in vitro Faltungsprozess und in den Hefemitochondrien. 
Im Gegensatz zu den vorherrschenden intrazellulären Ionenkonzentrationen, ist ai5γ in vitro auf 
hohe Salzkonzentrationen angewiesen um den selbst-spleiß Prozess durchzuführen. Besonders 
die Komprimierung des Introns ist limitiert von der Formation eines instabilen 
Faltungsintermediates, welches durch die Bindung von Mg2+ Ionen stabilisiert wird. Mg2+ Ionen 
sind bekannt dafür eine überaus wichtige Rolle in der Förderung des langsamen ai5γ  
Faltungskollapses in vitro zu spielen. Es wurde beobachtet, dass eine kernkodierte DEAD-box 
Helikase, welche als Spleißfaktor für alle mitochondrialen Introns in Hefe dient, die Mg2+ 
Anforderung in vitro auf zelluläre Konzentration senken kann. Kürzlich wurde Mss116p die 
Funktion zugewiesen, die Komprimierung von ai5γ in vitro zu beschleunigen. Deshalb sind wir 
überaus interessiert daran, ob Mss116p den Intron-Faltungsprozess über die Stabilisation des 
instabilen geschwindigkeitsbeschränkenden Faltungsintermediates stimuliert. Um dieses Ziel zu 
erreichen muss zuerst rekombinantes Mss116p Protein hergestellt werden. Nach Entwicklung 
eines adäquaten Expressions- und Aufreinigungsprotokolls wird Mss116p auf die Aktivität und 
Funktionalität überprüft. Im Detail zeigen wir, dass Mss116p im Stande ist ATP, in Abhängigkeit 
von RNA, zu hydrolysieren und dass es den ai5γ Gruppe II Intron Selbst-Spleiß-Prozess unter 
beinah-physiologischen Ionenkonzentrationen und Temperaturbedingungen fördert. Zuletzt 
wurde eine Methode entwickelt um die Struktur von ai5γ in Ab- und Anwesenheit von Mss116p in 
vitro zu ermitteln wobei wir Metall-Ionen-induzierte Schnitte als mächtiges Instrument zur Hilfe 
nehmen. Unsere bislang erlangten Daten deuten auf weitere wichtige Optimierungsschritte der 
Tb3+ Schnittbedingungen hin um die Metall-induzierten Schnittstellen über eine Reverse 
Transkription visualisieren zu können.  
140 
Curriculum Vitae  
 
 
 
Personal information 
 
First name(s) / Surname(s)  Eva Maria Steiner 
Address(es) Holzhäuser 13, 4632 Pichl/Wels, Austria 
Mobile: +43 (0)680 21 59 006   
E-mail eva.m.steiner@gmail.com 
  
Nationality Austrian 
  
Date of birth 04.12.1984 
  
Work experience  
  
Dates October 2010 – Present  
Occupation or position held Master Student at Max F. Perutz Laboratories (MFPL)  
Main activities and responsibilities ‘The Activity of recombinant DEAD-box Protein Mss116p:  
Towards its Role in the Collapse of the Ai5γ Group II Intron 
Protein purification and functionality assays, structural probing of RNA 
Name and address of employer Christina Waldsich 
Dr. Bohrgasse 9/5, 1030 Vienna, Austria 
  
  
Dates August 2010 – September 2010 
Occupation or position held Internship at MFPL 
Main activities and responsibilities ‘Do DEAD Box Proteins Assist td Group I Intron Splicing in vivo?’ 
cloning, in vivo splicing assays 
Name and address of employer Christina Waldsich 
Dr. Bohrgasse 9/5, 1030 Vienna, Austria 
  
  
Dates September and December 2009 
Occupation or position held Internship at MFPL 
Main activities and responsibilities Mss116p Protein Purification 
Name and address of employer Christina Waldsich 
Dr. Bohrgasse 9/5, 1030 Vienna, Austria 
  
  
Dates October 2008 – November 2008 
Occupation or position held Bachelor Student at MFPL 
Main activities and responsibilities ‘Rad61 Promotes the Association of Meiotic Cohesin with Chromatin’ 
FISH, yeast genomics 
Name and address of employer Franz Klein 
Dr.-Bohr-Gasse 1, 1030 Vienna, Austria 
141 
  
Education and training  
  
 
Dates 
 
April 2009 – Present  
occupational skills covered Master Student 
Biochemistry, Bioinformatics, Molecular Biology 
Name and type of organisation  University of Vienna, Austria 
Received Performance-based Scholarship in 2010 
 
 
 
Dates 2007 – 2009  
Title of qualification awarded BSc 
occupational skills covered Biology, Molecular Biology 
Name and type of organisation  University of Vienna, Austria 
 
 
 
Dates 2005 – 2007  
occupational skills covered Molecular Biology 
Name and type of organisation  Paris Lodron University of Salzburg and Johannes Kepler University of Linz 
 
 
 
Dates 2005 SS 
occupational skills covered Economy and Law 
Name and type of organisation  
 
Paris Lodron University of Salzburg 
 
 
 
Dates Oct. 2004 – Feb. 2005 
Name and type of organisation  A1 Mobilkom Austria at Linz Taubenmarkt, Upper Austria 
Sales and Advisory Service 
 
Dates 1999 – 2004 
Name and type of organisation 
  
Commercial Academy for Information Technology 
Kirchdorf an der Krems, Upper Austria 
 
Dates 
 
1995 – 1999  
Name and type of organisation  Bundesrealgymnasium  
Kirchdorf an der Krems, Upper Austria 
 
 
  
Dates 1990 – 1995  
Name and type of organisation  Elementary School  
Kirchdorf an der Krems, Upper Austria 
 
  
142 
Personal skills and 
competences 
 
  
Mother tongue(s) German 
  
Other language(s) English (Proficient User), Italian (Independent User),  
Swedish (Basic User) 
 
Social skills and competences Reliable 
Communicative 
  
Organisational skills and 
competences 
Creative 
Well-organised 
- During my master thesis I supervised an RNA practical course at the  
FH Campus Vienna and students in the laboratory of Christina Waldsich 
  
  
Computer skills and competences - Good command of Microsoft Office™ tools  
(Word™, Excel™, Access™ and PowerPoint™); 
- Basic knowledge of graphic design applications  
(Adobe Products like Adobe Photoshop™); 
- Basic knowledge in programming (Perl and C++) 
- Familiar with Linux and Unix operating systems 
   
Artistic skills and competences Tennis Trainer License, Classical Voice Education 
- I regularly organized and held kids tennis lessons  
  
  
Driving licence B 
  
  
  
 
 
 
References 
 
 Dr. Christina Waldsich 
Max F. Perutz Laboratories 
Department of Biochemistry & Cell Biology 
Dr. Bohr-Gasse 9, 1030 Vienna | Room: 5.512/5.513 
Mail: christina.waldsich@univie.ac.at 
Phone: +43-1-4277-52818 
Web: http://www.mfpl.ac.at/mfpl-group/group/waldsich.html 
 
 
 Prof. Dr. Franz Klein 
Max F. Perutz Laboratories 
Department of Chromosome Biology 
Dr. Bohr-Gasse 1(VBC2), 1030 Vienna | Room: 1. OG 7 
Mail: franz.klein@univie.ac.at 
Phone: +43-1-4277-56220 
Web: http://www.mfpl.ac.at/mfpl-group/group/klein.html 
 
  
 
